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1. Gap junctions spelen een belangrijke rol bij de weefseldistributie van 
reactieve intermediairen. 
Dit proefschrift. 
2. Bij onderzoek naar het vermogen van stoffen om intercellulaire 
communicatie te remmen is het gebruik van celtypen met een adequaat 
vermogen tot biotransformatie essentieel. 
Dit proefschrift. 
3. De antimutagene effecten van ß-NF kunnen niet worden toegeschreven aan 
het enzym-inducerend vermogen van deze verbinding. 
Dit proefschrift. 
4. Beïnvloeding van biotransformatie processen door indolen kan, afhanke-
lijk van de keuze van het precarcinogeen, leiden tot zowel een groter 
als een kleiner effect van blootstelling en de term "inhibitors", 
algemeen gebruikt om dit type effect te categoriseren, dient te worden 
vervangen door "modulators". 
Ramel et al., Mutation Res., 168, 47. 
Pence et al., (1986), J. Natl. Cancer Inst., 77, 269 
Dit proefschrift. 
5. Bij onderzoek naar mutagene en carcinogene eigenschappen van stoffen 
voorkomend in voedingsmiddelen dient meer aandacht te worden besteed 
aan matrixeffecten. 
Jongen and Dorgelo, (1986), Beth. J. Agric. Sei., 34, 395. 
Jongen et al., (1987), Pd. Chem. Toxic, 25, 141. 
6. De rol van endogene vorming van N-nitroso verbindingen bij het ont-
staan van kanker bij de mens kan pas reëel worden geschat wanneer de 
bijdrage van niet-vluchtige en cyclische N-nitroso verbindingen vol-
doende is uitgezocht. 
V. Broekhoven et al., (1987), Proc. IXth Int. Symp. on N-nitroso 
Compounds, IARC Scient. Publ., 84, 360. 
Wakabayashi et al., (1985), Mutation Res., 143, 17. 
7. Voedingsadviezen m.b.t. de preventie van kanker zijn pas gerechtvaar-
digd als ze gebaseerd zijn op inzicht in de oorzakelijke verbanden 
tussen de betreffende voedingsfactoren en de waargenomen effecten. 
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8. De conclusie van Peraino et al. dat het beschermend effect van gelijk-
tijdige toediening van phénobarbital en levercarcinogenen berust op 
een verandering van de biotransformatie stoelt niet op experimenteel 
bewijs. 
Peraino et al,, (1983), Multistage Hepatoeareinogenesis, In: T.J. 
Slaga, (Ed.), Mechanisms of Tumor Promotion, Vol. I, CRC Press, 1. 
9. De hardnekkige pogingen om met steeds andere combinaties van mutage-
niteitstoetsen de voorspellende waarde t.a.v. carcinogene potentie van 
stoffen te vergroten getuigen van een gebrek aan inzicht in de complexi 
teit van het proces. 
10. De veranderingen in de financieringsstructuur van het wetenschappelijk 
onderzoek leiden tot het prematuur uitdragen van onderzoeksresultaten 
en dragen op die manier bij aan een negatieve beeldvorming over de 
waarde van het wetenschappelijk onderzoek. 
11. De wijze waarop in Nederland het tweede fase onderwijs wordt ontwik-
keld getuigt meer van burgerlijke koopmansgeest dan van liefde voor de 
wetenschap. 
12. Het autorijden wordt zuur betaald. 
Stellingen behorend bij het proefschrift: Co-cultivation of cells as a 
promising tool in cancer research in vitro. 
Wim M.F. Jongen, 12 februari 1988. 
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dit proefschrift. Ik noem geen namen omdat het risico iemand te vergeten te 
groot is. Het feit dat sommigen van hen hun naam als mede-auteur genoemd zien 
wil niet zeggen dat anderen dus een minder belangrijke bijdrage hebben gele-
verd. Samenwerken met jullie was heel stimulerend en ik hoop dat dat weder-
zijds is geweest. 
Ook de samenwerking met de andere collega's van de vakgroep toxicologie was en 
is stimulerend. Gerrit, Peter, Hans T., James, Berend, Irene, Hans v.d. B., 
Alberto, Ineke, Jos, Ria, Ben, Bert, Rixta, Marleen, Ietje, Gré, Anja, 
Querien, Marianne, Mar ja, Folke, en last but not least, Hans v. H., bedankt 
allemaal. Dankzij Anja's deskundige hulp heb ik me het werken met de tekst-
verwerker snel eigen kunnen maken. Als de nood het hoogst is Marius, 
bedankt voor je spontane hulp bij het printen. Irene, bedankt voor je zorg-
vuldige correcties. Jo Haas en zijn mensen van het CKP hebben vakkundig zorg-
gedragen voor de vele kippe-embryo' s. De vakmensen van de tekenkamer van het 
Biotechnion en fotolocatie De Dreijen verzorgden de plaatjes in en op dit 
proefschrift. 
Vooral de laatste periode die ik met het proefschrift bezig was heeft een 
grote druk op het gezinsleven gelegd. Ine, Freek en Joost: het is af, bedankt 
voor jullie geduld. 
CHAPTER I 
GENERAL INTRODUCTION 
THE CANCER PROCESS 
Cancer is the name for a number of different types of diseases which have in 
common that a group of cells has escaped growth control and grow more or less 
autonomously. Such a group of cells almost always is clonal i.e. originates 
from one deviating cell. There is considerable epidemiological and experimen-
tal evidence showing that the process of tumor formation in humans and expe-
rimental animals proceeds stepwise. Such events may be caused or at least 
largely be influenced by exposure to certain chemicals, various forms of 
radiation and viruses. 
Studies in experimental animals showed that in the stepwise development of 
tumors both genetic and epigenetic factors play an important role. Also for 
the human situation there is sufficient evidence to assume that similar pro-
cesses contribute to the incidence in tumor formation. The involvement of 
genetic factors in the etiology of human cancer has been observed in various 
studies. The existence of familial derived predisposition for certain types of 
cancer like retinoblastoma or polyposis coli has been established and at the 
present a significant number of different hereditary traits have been des-
cribed which predispose to cancer. The genetic alterations underlying these 
traits include both point mutations and chromosome aberrations (McKusick, 1983 
; Mulvihill, 1984). 
Epidemiological data provided further evidence that genetic changes in somatic 
cells are an important causative step in the onset of carcinogenesis (Friesen 
et al., 1985; Bartsch and Montesano, 1984). 
Among members of a Chinese population the high incidence of oesophageal cancer 
is associated with the presence of increased amounts of carcinogenic N-nitroso 
compounds present in the food. Analysis of the DNA from oesophageal cells 
revealed that persons bearing tumors had substantially higher levels of modi-
fied DNA bases than non-affected individuals (Umbenhauer et al., 1985). 
On the other hand, the apparent multistep nature of chemical carcinogenesis 
and the often long latency time between the first exposure to a carcinogen and 
the manifestation of tumors indicates that epigenetic mechanisms play also an 
important role in this process. 
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On the Carribean island Curacao the black and créole population suffers from 
an exceedingly high rate of oesophageal cancer compared with the incidence on 
surrounding islands. Through epidemiological investigations it was established 
that on the island, as part of local life-style, the fresh green aromatic 
leaves of the bush Croton flayens L. are used to make a 'bush tea' drunk as an 
everyday beverage. 
The leaves of this plant contain a large number of non-mutagenic, tumor promo-
ting agents including 12-0-tetradecanoyl-13-phorbolacetate (TPA) the strongest 
known tumor promoter (Hecker et al., 1983; 1984). 
Since the discovery of Rehn in 1895, that aniline workers developed a high 
rate of bladder cancer much attention has been paid to chemical carcinoge-
nesis. On the basis of these studies a theory has been developed which implies 
that chemical carcinogenesis proceeds according to a sequence of three more or 
less distinct phases: the initiation phase, the promotion phase and the pro-
gression phase (Hecker et al., 1984; Emmelot and Scherer, 1980; Goldsworthy 
and Hanigan, 1987). 
In this context initiation can be defined as a relevant irreversible change in 
the genome of a cell leading to a change in the genetic properties of that 
cell. Promotion is that part of the process whereby initiated cells in a 
tissue or organ develop focal proliferations such as nodules, papillomas and 
polyps. In the progression phase, probably due to additional genetic damage, 
one or more of these focal proliferations undergo a cellular evolution to 
malignant neoplasm. 
Some chemical compounds have initiating capacities but exposure to these com-
pounds alone does not lead to the induction of tumors. Other compounds cannot 
initiate the process of carcinogenesis but are able to make initiated cells 
develop into visible tumors. In addition there are the so-called complete 
carcinogens which might be described as having both initiating and promoting 
capabilities. Exposure to the latter compounds alone can lead to the induction 
of tumors. 
The functional differences between initiators and promoters arises from their 
mode of action. Initiators react with the DNA of the cells thus causing gene 
mutations or chromosomal damage. In fact they change the genotype of the cell. 
The view is held that pure promoters cannot bind to DNA or give rise to muta-
tions. Their mode of action is a stimulation of cell proliferation of initia-
ted cells which can be brought about by various mechanisms like cell killing 
or specific mitogenic stimuli. 
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INITIATION 
Initiation is the genetic event which is considered to be the first step in 
the onset of chemical carcinogenesis. Although a chemical that can bind 
covalently with DNA will do so largely at random, only specific lesions will 
result in genetic alterations that are relevant for the cancer process. In 
this respect the discovery of the existence of human cellular oncogenes in the 
beginning of the 1980s clearly was a major step forward. Oncogenes are a 
family of genes which are involved in cellular processes regulating growth and 
differentiation (Yarden et al., 1986; Dmitrovsky et al., 1986). Under normal 
conditions they are expressed only during restricted periods of differentia-
tion and organ development. Many human tumors contain activated oncogenes 
which show enhanced expression or synthesize altered gene products. This ac-
tivation results from chromosome rearrangements, insertion of foreign DNA 
sequences or point mutations (Capon et al., 1983; Rechavi et al., 1982; Santos 
et al., 1983). 
The initiation phase comprizes two distinct steps, the induction of the mole-
cular lesions and the fixation of these lesions by DNA replication. 
The vast majority of chemical mutagens, either with or without metabolic ac-
tivation, react with cell constituents including DNA. 
These alterations in the genome can be classified in two categories: 
a. Point «utations 
Point mutations are changes at the gene level and two types can be recognized. 
Base pair substitutions: Alkylating agents produce chemical changes in nucleo-
tides. At the next replication the altered base may select a "wrong" partner 
e.g. an alkylated guanine selects thymine instead of cytosine and after two 
rounds of replication the GC base pair has been substituted by an AT base 
pair. Another possibility is that the alkylated base is removed either sponta-
neously or enzymatically and that "error prone" repair puts in the wrong base. 
Frame shift mutations: Compounds may produce frame shifts by insertion or 
deletion of one or several contiguous bases within a gene. Frame shifts can 
beproduced either by covalent binding or by intercalation of flat aromatic 
structures. 
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b. Chroaosone aberrations 
Primary damage to individual chromosomes consists of breakage of chromatids 
which results from a discontinuity of both strands of the DNA in a chromatid. 
Chromosome breaks may undergo three different fates with quite different con-
sequences for the cell. 
1. Enzymatic repair processes restitute the original situation. 
2. The fragments remain unjoined in the cells. This almost always results in 
cell death at the next or one of the folowing mitoses. 
3. The fragments are rejoined in an order different from the old one resulting 
in chromosome rearrangements like translocations, inversions and deletions. 
Fixation of lesions in the DNA is held to be an essential step in initiation. 
One way to bring about fixation of these lesions is cell proliferation. In 
experimental animals cell proliferation plays an important role in the fixa-
tion of altered DNA sequences and, depending on the type of organ or tissue, 
fixation occurs automatically or must be brought about with exogenous stimuli. 
For example, in organs or tissues like colon, skin and bone marrow cell proli-
feration is an ongoing property and fixation of lesions in the DNA occurs 
automatically. In adult animals for instance in the liver, due to the 
quiescent nature of this organ with respect to cell proliferation, fixation of 
DNA lesions will be largely increased by exogenous stimuli like partial hepa-
tectomy, induction of liver cell necrosis or treatment with chemical mitogens. 
In neonate or very young animals this need for cell proliferation is fulfilled 
automatically because almost all organs contain dividing cells (Färber and 
Sarma, 1987). Various types of DNA damage caused by chemical carcinogens 
elicit DNA repair. This role of the various DNA repair enzyme systems is 
essential in the preservation of the genetic properties (Lehman and Karran, 
1981; Maher, 1979). Basic "error proneness" of the processes involved in the 
processes underlying this preservation may also lead to fixation of DNA 
lesions (Singer and Kroger, 1979; Scherer, 1984). 
PROMOTION 
Promotion is the process whereby an initiated tissue or organ develops focal 
proliferations of phenotypically altered cells. Promotion of initiated cells 
can be brought about by a variety of factors like wounding, bacterial and 
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viral infection, hormones, growth factors and by xenobiotic compounds (Slaga, 
1984). 
Animal studies showed that exposure to promoters must be repeated and not to 
much spaced in time. The process of promotion, in its first phase, is rever-
sible to a certain extent (Verma and Boutwell, 1980; Hecker et al., 1984). In 
addition promoters appear to act only above a certain threshold level (Verma 
and Boutwell, 1980). The proliferative stimulation necessary for the promotion 
of initiated cells can be brought about by either cell killing or specific 
mitogenic stimuli. Evidence exists, demonstrating that unless a DNA damaging 
agent produces significant cell killing, as well as mutations, exogenous 
promoters must be present in order to obtain tumors (Frei, 1976; Trosko and 
Chang, 1984). This implies that the only difference between an initiator and a 
"complete" carcinogen might be the ratio between the initiating capacity and 
the toxic potential. At cytotoxic levels of a xenobiotic compound the survi-
ving cells, including the initiated cells, are forced to repopulate the necro-
tic tissue. The same mode of action also holds for treatments like partial 
hepatectomy. 
In addition to this aspecific type of effect promotion can be brought about by 
specific mitogenic stimuli. For instance growth factors or hormones have been 
shown to behave like promoters (Desser-Wiest, 1979; Sonnenschein and Soto, 
1980; Paranjpe et al., 1980; Takizawa and Hirose, 1978; Yoshida et al, 1980) 
and other types of promoters can interfere with growth factor pathways e.g. by 
influencing receptor affinity and binding sites (Farrar et al., 1985; Fearon 
et al, 1985; Lee and Weinstein, 1980; Wolf et al., 1984). 
In vitro studies have shown that many of these proliferative stimulations are 
triggered by a promoter-membrane interaction. Structural and functional chan-
ges in cellular membranes have been reported, activation or inhibition of 
various plasma membrane bound enzymes, modulation of ion transport and trans-
port of small molecules through membranes (for reviews see Yamasaki, 1984; 
Muf son, 1984; Trosko and Chang, 1984). Much of the knowledge obtained on the 
mode of action of tumor promoters has come from studies with phorbolesters and 
their derivatives (Hecker et al., 1984; Yamasaki, 1985). The mode of action of 
other types of tumor promoters has been studied much less intensively. The 
reported diversity of effects of tumor promoters on cultured cells is enormous 
and those considered to be relevant for understanding the mechanisms of the 
process of tumor promotion shall be reviewed in a bird's eye view. 
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Specific binding to cellular receptors 
Biochemical studies have shown that phorbolesters have special interactions 
with cellular membranes. Phorbolesters which are active tumor promoters stimu-
late the phospholipid metabolism in vitro and in vivo (Suss et al., 1971; 
Kreiblich et al., 1971; Rohrschneider et al., 1972) whereas non active phorbol 
derivatives don't affect this metabolism (Suss et al., 1972). 
Direct research towards the mechanisms of this interaction became possible 
when Driedger and Blumberg (1980) reported the existence of specific receptors 
localized in the plasma membrane. Since then a large number of eukaryotic 
cells were shown to possess this specific receptor (Delclos et al., 1980; 
Verma et al., 1985; Shoyab et al., 1981; Jaken et al., 1981). 
Binding was not observed in prokaryotic cells (Driedger and Blumberg, 1980) 
and erythrocytes (Shoyab et al., 1981). Binding characteristics of 
phorbolester-sensitive cells proved to be very similar for a wide range of 
cell types and tissues suggesting a fundamental role of the receptor in multi-
cellular organisms. (Shoyab and Todaro, 1980). Further characterization of the 
binding site has revealed that the phorbolester receptors co-purify with pro-
tein kinase C, a phospholipid dependent enzyme. In vitro and in vivo studies 
have shown that the active phorbolester derivatives activate this enzyme 
(Niedel et al., 1983; Nishizuka, 1984; Castagna et al., 1982). 
In conclusion, it seems reasonable to suppose that protein kinase C is part of 
the phorbolester receptor. 
Protein kinase C is a Ca^+ and phospholipid dependent enzyme (Nestler and 
Greengard, 1983). The enzyme is present in all eukaryotic cells investigated 
(Kuo et al., 1980; Kikkawa et al., 1982; 1983) and is constituted of two func-
tional differing peptides which can be separated by Ca^+ dependent thiol pro-
teases (Kikkawa et al., 1982). 
The hydrophobic part binds to cellular membranes and the hydrophilic part 
carries the catalytic centre. The enzyme has been found both in membranes and 
in cytosolic fractions. 
Activation occurs through translocation of the cytosolic fraction towards the 
plasma membrane where binding occurs (Kraft and Anderson, 1983). Further re-
search revealed that in most cells protein kinase C is present in the cytosol 
in an inactive form which, after stimulation, binds to cellular membranes 
(Nishizuka, 1984). When hormones or growth factors interact with receptors on 
cellular membranes the inosotol phospholipid turnover is transiently activated 
and produces diacylglycerol which activates protein kinase C. Tumor promoting 
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phorbolesters like TPA are intercalated into the membrane, substitute for 
dlacylglycerol and permanently activate protein kinase C, in spite of the 
presence of a feed back control mechanism (Farrar et al., 1985; Fearon et el., 
1985; Miyaké et al., 1984; Wolf et al., 1985). 
Activation of protein kinase C triggers a cascade of biochemical responses 
like ornithine decarboxylase actvity, receptor binding of epidermal growth 
factor, synthesis of prostaglandins and cyclic GMP, production of arachidonic 
acid, activation of transglutaminase and inhibition of intercellular communi-
cation. Furthermore the phorbol ester mediated differentiation of HL60 cells 
probably proceeds via protein kinase C. 
In addition to the active phorbolesters also teleocidine and aphlysiatoxine, 
both strong tumor promoters in the mouse skin, induce similar effects (Sugi-
mura and Fujiki, 1983). 
On the other hand known tumor promoters like phenol, oleic acid, saccharin and 
cyclamate don't influence phorbol ester binding to cellular receptors and 
known inhibitors of tumor promotion like retinoic acid, dexamethasone and 
disulfiram don't influence this binding (Shoyab and Todaro, 1980). 
Modulation of cell differentiation 
Already in 1954, Berenblum hypothesized that the mechanisms of tumor promotion 
in mouse skin could involve a delay in cell maturation (Berenblum, 1954). 
Indeed phorbolesters tumor promoters are able to modulate a variety of cell 
differentiation programmes resulting in both inhibitory and stimulating 
effects. (Diamond et al., 1980; Yamasaki, 1984). It seems reasonable to sup-
pose that only inhibition of cell differentiation is responsible for tumor 
promotion, since accumulation of continuous dividing stem cells is attained 
(Yamasaki, 1980). Beside this, initiation-promotion studies in experimental 
animals show that the promotion of initiated cells is always associated with 
de-differentiation (Scherer, 1984). 
The reversibility of phorbolester mediated inhibition of cell differentiation 
has been studied the most extensively in Friend erythroleukemia cells (FELC) 
(Rovera et al., 1977; Yamasaki; 1984) and chick embryo cells (Holtzer et al., 
1982; Payette et al., 1980). It was shown that exposure to the phorbolesters 
did not influence cell division rate and normal FELC proliferation (Yamasaki 
et al., 1982). This suggests that only gene expression which is directly 
related to differentiation is influenced and not that necessary for main-
tenance of cell proliferation. 
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Phorbolester mediated inhibition of cell differentiation is observed in a 
tremendous diversity of differentiation programmes affected (Yamasaki, 1984). 
For instance a single compound like TPA can inhibit differentiation of cells 
that are committed for erythroid, chondrogenic, melanogenic, myeblastoid, 
neuroblastoid and epidermal lineages. What are the mechanisms by which such a 
variety of programmes are selectively influenced ? For one it is well esta-
blished that intercellular communication plays an important role in the con-
trol of cellular differentiation. Secondly it has been reported that many 
tumor promoters inhibit intercellular communication (Yotti et al., 1979; 
Murray and Fitzgerald, 1979; Trosko et al., 1982). Therefore it seems likely 
that phorbolester mediated inhibition of intercellular communication itself is 
the cause of aberrant gene expression. 
Inhibition of intercellular cooaunication 
Communication between cells in a living organism is supposed to play a funda-
mental role in the regulation of cell proliferation and differentiation 
(Loewenstein, 1979). There are two major pathways for intercellular communi-
cation. It can take place via the intercellular space and is then regulated by 
production and transmission of signal molecules like hormones and growth fac-
tors which act through receptor binding to cellular membranes. Between neigh-
bouring cells, permeable intercellular junctions can be formed which allow for 
a direct passage of signal molecules (Trosko and Chang, 1984). 
In vivo these gap junctions occur in most mammalian cell types. Exceptions to 
this rule are the striped muscle cells and some nerve cells (Loewenstein, 
1979, Larsen, 1983). The relative amount of cellular membrane involved in gap 
junction formation may vary in time and between tissues, ranging from 0.05% 
for the BHK cell line to 7-8% for granulocytes in the follicles of rabbits 
(Yee and Revel, 1978; Yancey et al., 1982; Larsen, 1983). In addition to gap 
junctions formed between homologous cells also heterologous gap junctions can 
be formed. Cells and cell lines from different organs and even of different 
vertebrates can be manipulated in vitro to form gap junctions (Michalke and 
Loewenstein, 1971; Overton, 1974; Epstein and Gilula, 1977; Lawrence et al., 
1977; Gaunt and Shubak-Sharpe, 1979; Hooper, 1982; Jongen et al., 1987). The 
formation of gap junctions between cells of different origin indicates the 
fundamental role of this type of junction in intercellular communication. The 
transport capability allows for the passage of neutral and negatively charged 
molecules to a molecular weight up to 1000 and also small positively charged 
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molecules. The upper limit for positively charged molecules is unknown proba-
bly due to binding to cytoplasmic constituents (Simpson et al., 1977; Bennett 
and Goodenough, 1978). Transport of various types of compounds occurs like 
electrolytes, low molecular nutrients, waste products and signal molecules for 
growth and differentiation. Beside this gap junctions are essential for syn-
chronisation of contractile movements in heart- and smooth muscle tissue 
(Larsen, 1983; Peracchia, 1980). 
Figure I 
Tentative model of vertebrate gap junc-
tion a rch i t ec tu re in coupled (a) and 
uncoupled (b) conditions. Intramembrane 
part icles composed of six subunits span 
the membrane th ickness and bind to 
similar part icles of the adjoining mem-
brane. Channels (1.5-2.0 nm wide) span 
the junctional membranes at the center of 
the p a r t i c l e s providing cytoplasmic 
bridges for c e l l - t o - c e l l diffusion of 
small molecules. The intramembrane par-
t ic les form loose and disordered arrays 
in coupled junctions (a) and more ordered 
packings in uncoupled junctions (b) , up 
to crystal l ine (hexagonal) arrays with a 
periodicity of 8.5 nm. (From Peracchia 
and Bernardini, 1984). 
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Figure I I 
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Foto t aken from s e c t i o n e d , f reeze-etched mater ia l obtained from cul tured 
primary chick-embryo hepa tocytes . P ic tu re shows gap j u n c t i o n (Enla rgement 
186.340 x ) . Foto prepared by P . T . J , van der Zandt. 
Evidence tha t tumor promoters can i n h i b i t i n t e r c e l l u l a r communication was 
f i r s t obta ined, almost s imultaneously, by Yo t t i e t a l . (1979) and Murray and 
F i t zge ra ld (1979). Studies of Yancey e t a l . (1982), Kalimi and S i r s a t (1984) 
and Jongen e t a l . (1987) have shown tha t add i t ion of the phorboles te r TPA 
decreased the number of gap junc t ions in cu l tured c e l l s as well as in expe r i -
mental animals (mouse s k i n ) . 
I n h i b i t i o n of i n t e r c e l l u l a r communication has been s tudied in a va r i e ty of 
cu l tured c e l l s by means of t r a n s f e r of labeled n u c l e o t i d e s , t r a n s f e r of 
poisonous base analogues, e l e c t r i c a l coupling and dye t r a n s f e r methodes (Yot t i 
e t a l . , 1979; Murray and F i t z g e r a l d , 1979; Loewenstein, 1979; Williams e t 
a l . , 1981; Telang e t a l . , 1982; Trosko e t a l . , 1980, 1983; Enomoto e t a l . , 
1984, a, b ) . 
Evidence has been obtained which shows tha t many types of promoting agents 
i n h i b i t i n t e r c e l l u l a r communication and tha t the in vivo tumor promoting capa-
b i l i t y c o r r e l a t e s wel l with the c a p a b i l i t y to i n h i b i t i n t e r c e l l u l a r communica-
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tion (Trosko et al., 1982). Moreover, there Is a good correlation between 
phorbolester mediated inhibition of intercellular communication and enhance-
ment of cell transformation in BALB/c 3T3 cells (Yamasaki, 1984). Chemically 
transformed cells have deviating communication characteristics from those of 
nontransformed cells. In some instances they don't communicate at all 
(Fentiman et al., 1979; Wiener and Loewenstein, 1983) while in other cases 
they don't communicate with surrounding non-transformed cells. Also, anti-
tumor promoting agents like retinoic acid and dexamethasone antagonize the 
phorbolester mediated inhibition of intercellular communication (Shuin et al., 
1983; Yamasaki, 1984; Nishino et al., 1984). Recently, several oncogene pro-
ducts such as from the src and ras now have shown to be associated with a 
decrease in gap junctional communication (Atkinson and Sheridan, 1984; Azarnia 
and Loewenstein, 1984; Chang et al., 1985). Beside this it is well known that 
partial hepatectomy and repeated wounding can act as tumor promoters in the 
two stage model. Therefore the observation that under these circumstances a 
decrease in both the number and the size of gap junctions is found supports 
the hypothesis that inhibition of intercellular communication plays an 
essential role in tumor promotion. 
PROGRESSION 
Progression is that part of the process whereby one or more focal prolifera-
tions undergo a cellular evolution to malignant neoplasm. During this evolu-
tion these cells acquire several characteristics which can be divided in the 
following categories (Ponten, 1987; Scherer, 1984): 
- infinite growth. There is an indefinite expansion of the net cell number in 
a tumor resulting in a progressive increase in tumor burden. 
- genetic instability. Within a tumor new abnormal genotypes are created and 
fixed implying a considerable risk of loosing important proliferation and 
differentiation controls. 
- irregular migration. Cells acquire invasive properties which means that they 
have the potential to migrate, settle and grow at abnormal locations in the 
organisms. In experimental animals progression is accomplished by addition 
of initiating agents like urethane or dimethylbenzanthracene which induce 
additional genetic changes (Färber and Sarma, 1987; Hecker et al., 1984). 
The development of malignant tumors from pre-existing preneoplastic lesions or 
from benign tumors is one of the least studied processes in carcinogenicity 
studies in experimental animals (Färber and Sarma, 1987). 
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THE USE OF INTACT CELLS AS METABOLIZING SYSTEM; 
OBJECTIVES OF THE INVESTIGATIONS 
Biotransformation of xenobiotics 
Living organisms are continually exposed to a variety of naturally occurring 
and synthetic chemicals. If these compounds are lipophilic they are generally 
made more hydrophilic by metabolic transformations, mainly oxidations or 
hydroxylations, and subsequent conjugations, to facilitate excretion. This 
capacity to deal with lipophilic xenobiotics used to be considered a defense 
mechanism of the organism. The last decades, however, an overwhelming amount 
of information has been gained, which indicates that in the process of conver-
sion of the non-reactive parent compounds to hydrophilic metabolites reactive 
intermediates can be formed which may have toxic effects. In this connection 
it was the concept of the 'ultimate carcinogen' as an electrophilic species, 
which binds covalently to the DNA, that has led to the realisation that the 
majority of known initiating carcinogens is not reactive per se but must be 
transformed enzymatically into reactive products (Brookes and Lawly, 1964; 
Miller, 1970). This process of metabolic transformations can be divided in 
two phases. Phase I reactions introduce new functional groups into the lipo-
philic compounds converting them into highly reactive products which can bind 
covalently to nucleophilic molecules (Wright, 1980). These transformations are 
oxidative processes like hydroxylations, epoxydations, oxidative dealkylations 
and deaminations, reductions and hydrolyses. Phase II metabolism comprizes 
synthetic reactions with small endogenous molecules that are coupled to func-
tional groups originally present or introduced by phase I metabolism. The main 
phase II reactions are glucuronic acid conjugation, mercapturic acid forma-
tion, sulfate conjugation, methylation, acetylation and amino acid conjuga-
tion. It should be emphasized that even if phase II enzymes in the vast 
majority of cases provide an efficient protection against toxic intermediates 
in several cases cause activation of the parent compound into highly reactive 
products (Irving, 1979; Rannug et al., 1978; van Bladeren et al, 1980a, b; 
Jongen et al., 1982). 
Modulation of biotransformation 
The ability of mutagens to exert their effects depends largely upon the 
balance between activating and deactivating enzymes. Any change in this 
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balance will result In a change in genotoxic effects. Many environmental fac-
tors are known to be able to induce or inhibit the metabolism of xenobiotics. 
Some well known enzyme inducers are phénobarbital, 3-methylcholanthrene, mix-
tures of poly chlorinated biphenyls and cigarette-smoke condensate. The 
influence of dietary related factors may be apparent from the observation that 
when rats were fed with a guinea-pig diet the B(a)P hydroxylase activity was 
10 fold enhanced when compared with the activity on a normal diet (Hietanen 
and Vainio, 1973). Many compounds, naturally occurring in the human diet, 
modulate the biotransformation of several precarcinogens, resulting in a re-
duced tumor incidence (Ramel et al., 1986). This implies compounds which 
inhibit the formation of electrophilic intermediates by acting as inducers of 
alternative pathways of metabolism as well as compounds which change the 
balance between activating and deactivating enzyme systems (Mirvish, 1981; 
Newmark and Mergens, 1981; Wattenberg, 1979, 1980, 1983; Wood et al., 1982). 
Studies performed sofar have shown that there is a good correlation between 
the enzyme inducing capability of several dietary related compounds and their 
potential to inhibit carcinogenesis (Sparnins et al, 1982). As Ramel (1986) 
pointed out, most work in this area is still on a basic and exploratory level 
and a basic knowledge of the mechanism behind such interactions is evidently 
of great importance before this information can be used for practical actions. 
Isolated hepatocytes in 'in vitro' studies 
The liver is the organ predominantly involved in the biotransformation of many 
xenobiotics. For practical purposes, in the majority of in vitro studies liver 
homogenates or subcellular liver fractions have been used to mimic in vivo 
metabolism. 
However the use of this kind of preparations has several disadvantages. Due to 
homogenization and fractionation of the cells the balance between activating 
and deactivating enzyme systems is disturbed. Especially conjugation reac-
tions, which are located in different cellular compartments are much less 
operative. Also, these preparations are equipped artificially with cofactors 
needed for optimal enzyme functioning (Brouns, 1981). 
The disadvantages mentioned may be overcome by the use of intact cells as 
metabolizing system. Isolated hepatocytes resemble in their structural and 
biochemical properties the in vivo situation much more closely than subcel-
lular fractions (Glatt et al., 1981; Green et al., 1977; Jones et al., 1978; 
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Kuroki and Drevon, 1978; Nordenskjó'ld et al., 1981; Strom et al., 1981; Neis, 
1986). The value of the use of intact cells for the assessment of the geno-
toxic effects of xenobiotics has been shown extensively by several authors 
(McMahon, 1980; Brouns, 1981; Gould, 1983; Neis, 1986; Roberfroid, 1980). 
When freshly isolated hepatocytes are cultured in vitro they have to adapt to 
the new environment. This adaptation takes about 24 hours (Princen et al., 
1984). Unfortunately, when primary hepatocytes are cultured they show a rapid 
decline in their biotransformational capacity e.g. cytochrome P450 catalyzed 
activities. To overcome this disadvantage several methods have been applied 
like addition of hormones, addition of enzyme inducers and co-cultivation with 
epithelial cells (Holme et al., 1983; Paine, 1980; Malansky and Williams, 
1982; Blaauboer et al., 1985; Quillouzo et al., 1985). In contrast to paren-
chymal cells isolated from mammmalian liver, chick-embryo hepatocytes maintain 
their initial levels of cytochrome P450 containing monooxygenases in vitro for 
at least 72 hours. Moreover, induction in vitro with known enzyme inducers 
like phénobarbital, 3 methyl-cholanthrene or Aroclor 1254 leads to a 2-2.5 
fold increase in cytochrome P450 content which is comparable with the in vivo 
situation (Althaus et al., 1979; Sinclair et al., 1979; Topp and van Bladeren, 
1986). This makes these cells a potentially useful tool to study the effects 
of modulating compounds. 
Sofar several sudies, using primary chick-embryo hepatocytes as metabolizing 
system, have shown that these cells are capable of bioactivation of a wide 
range of premutagens belonging to different chemical classes (Bruggeman and 
van der Hoeven, 1985; van der Hoeven et al., 1984; Jongen et al., 1985, 1986, 
1987). 
OBJECTIVES OF THE INVESTIGATIONS PRESENTED IN THIS THESIS 
Research on the relation between nutrition and cancer is still largely at an 
exploratory level. There is a lack of basic kowledge on the mechanisms behind 
such a relation. Obviously, mechanistic studies towards that relation require 
the use of adequate experimental systems. The use of primary chick-embryo 
hepatocytes, co-cultivated with V79 Chinese hamster cells, offers a potential-
ly useful model. The investigations presented in this thesis are directed to 
develop a model system enabling the study of effects of chemicals on various 
important aspects of the cancer process, in particular mutagenicity, metabolic 
cooperation and modulation of drug metabolism. For this purpose attention has 
been focussed on four aspects: 
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- The relation between the sensitivity of the co-cultivation system, the gene-
tic endpoint and the type of xenobiotic 
- Development of a model system to study the effects of agents known to modu-
late experimental carcinogenesis. 
- A detailed study on the transport of reactive intermediates from the meta-
bolizing cells into the target cells. 
- Development of a model system to study the process of metabolic cooperation 
between the primary chick-embryo hepatocytes and the V79 Chinese hamster 
cells. 
The results of these studies are presented in the chapters II-V and are based 
on already published papers and papers that are submitted or 'in press'. 
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PRINCIPLES OF THE TEST METHODS USED IN 
THE INVESTIGATIONS 
MUTAGENICITY TESTING 
In the l a s t two decades a la rge number of shor t - te rm t e s t systems have been 
developed with the aim to de tec t chemical mutagens and carc inogens . These can 
be divided in two main c a t e g o r i e s : systems using prokaryot ic c e l l s ( b a c t e r i a ) 
which are able to de tec t point mutations and small de l e t ions and systems with 
eukaryot ic c e l l s ( fungi , yeas t , mammalian c e l l s ) which a r e able to de tec t both 
point muta t ions , small de le t ions and chromosome a b e r r a t i o n s . 
In the present i n v e s t i g a t i o n s two shor t - te rm t e s t systems with mammalian c e l l s 
have been app l ied : the s i s t e r chromatid exchange (SCE) t e s t and the t e s t on 
forward m u t a t i o n a t t h e h y p o x a n t h i n e - g u a n i n e - p h o s p h o r i b o s y l - t r a n s f e r a s e 
(HGPRT) locus . 
Sister chromatid exchanges 
Sister chromatid exchanges are the result of reciprocal exchanges between 
sister chromatids at a homologous locus. In 1958, Taylor described the exis-
tence of this phenomenon in plant chromosomes using autoradiographic methods. 
Protocols applied nowadays usually include the use of 5-bromodeoxy-uridine, a 
thymidine analog. Incorporation of this compound for two rounds of replication 
results in chromosomes consisting of one unifiliarly substituted chromatid and 
one bifiliarly substituted chromatid. These chromatids stain differentially 
with Giemsa or fluorescent dyes. The best results are obtained with a combina-
tion of these (Zakharow and Egolina, 1972; Latt, 1973; Korenberg and 
Freedlender, 1974; Perry and Wolff, 1974). Although the molecular mechanisms 
of exchanges are largely unknown as yet, there are good indications that SCEs 
and chromosomal aberrations are caused by the same type of chromosome damage 
(Wolff, 1977). The test system is a sensitive indicator of the effects of 
chemical mutagens (Perry and Evans, 1975; Evans, 1982; Carrano et al., 1978; 
Latt et al., 1981). 
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Figure I 
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Foto showing metaphase of V79 Chinese hamster cell containing differential 
stained chromatids. Arrows indicate reciprocal exchanges between homologous 
sister chromatids. 
Forward mutation on the HGPRT locus 
Cultured mammalian cells follow two routes to provide in their need for puri-
nes and pyrimidines. In addition to the 'de novo' synthesis from simple pre-
cursors, cells have evolved salvage pathways for the recycling of bases from 
degraded DNA or RNA. Hypoxanthine and guanine are salvaged by the dual purpose 
hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT), an enzyme coded for 
by a gene on the X chromosome (Polani et al., 1981). When cells are cultured 
in the presence of the poisonous base analogue 6-thioguanine this compound 
will be incorporated into nucleic acids ultimately leading to cell death. Only 
mutated cells which lack the enzyme activity will survive in this selective 
medium. Because this is only a salvage pathway mutant cells can grow normally 
by the use of the 'de novo' synthesis. 
The general procedure is to expose cells to the mutagen and then allow them to 
grow in a non-selective medium for a longer period (expression time) which 
depends on the combination of cell type used and compound tested. After this 
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the cells are replated In a selective medium in which only the specific mutant 
will grow (van Zeeland and Simons, 1975 , 1976a, 1976b). 
IN VITRO TEST SYSTEMS FOR TUMOR PROMOTION 
So far two groups of test systems have been applied primarily for in vitro 
testing of tumor promoters. One group of test models (cell transformation) 
uses irreversible functional and morphological changes as endpoint whereas the 
other group measures inhibition of intercellular communication as endpoint. 
Inhibition of intercellular communication 
Several systems have been developed to measure inhibition of intercellular 
communication using different techniques. Trosko et al. (1982) co-cultivated 
the wild type of the V79 Chinese hamster cell line with a HGPRT deficient V79 
mutant. In this case the existence of metabolic cooperation between neigh-
bouring cells can be shown by the use of mutant cells which lack the salvage 
pathway to phosphorylate purines and pyrimidines. When these cells are co-cul-
tured with wild type cells in the presence of poisonous purine or pyrimidine 
analogues, the effect on the survival of the mutant cells is an index for 
metabolic cooperation.These mutants, when cultured alone, will survive in a 
selective medium in the presence of 6-thioguanine. When they are co-cultured 
with the wild type cells, the phosphorylated metabolite of 6-thioguanine is 
transferred through gap junctions from the wild type to the mutant cells. 
Ultimately this results in cell death for both cell types. When inhibition of 
metabolic cooperation occurs, the mutant cells will survive and form colonies. 
By varying exposure levels dose-effect relationships can be obtained which are 
indicative for the level of intercellular communication (Yotti et al., 1979). 
Another method to show metabolic cooperation has been presented by Subak-
Sharpe et al. (1969). In this system too wild type cells are co-cultured with 
HGPRT deficient mutants. During co-cultivation the cells are treated with a 
labeled purine or pyrimidine. After washing off the label, the mutants will 
only then incorporate label when the phosphorylated purine or pyrimidine is 
transferred into the mutant cells through gap junctions. This transfer can be 
quantitated by the use of autoradiographic methods. 
Pitts and Simms (1977) introduced a variant on this method which does not 
require the use of mutant cells. Donor cells are treated with a labeled pre-
cursor for instance uridine, and then washed with unlabeled medium. The uri-
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dine, remaining in the cells, is metabolized to the nucleotide. During co-cul-
tivation with non-labeled cells transfer through gap junctions can be measu-
red. Also here, quantitation of transfer is done with autoradiographic methods 
(Fitzgerald and Murray, 1979; Hunter and Pitts, 1981). 
Two techniques which are based on direct measurement of intercellular communi-
cation are electrical coupling and microinjection of a fluorescent dye. 
When electrical coupling is used, microelectrodes are placed on two adjacent 
cells. When cells are connected through junctional channels, the electrical 
current put onto the electrode in one cell will result in a current into the 
second cell which can be measured with a second electrode. If cells don't 
communicate, the current towards this second electrode will stay below the 
detection level. 
Microinjection uses the transfer of a fluorescent dye. The compound is injec-
ted into a single cell within a few seconds. The plasma membrane is imper-
meable for this type of compounds and transfer to surrounding cells is mea-
sured after 10 min by counting the fluorescent cells. Using this method it 
has been shown that inhibition of intercellular communication is reversible 
and that the amount of inhibition of compounds at equimolar doses correlates 
well with their in vivo promoter activity (Yamasaki, 1984; Enomoto et al., 
1984a, b). 
Figure II 
Foto showing f luoresc ing V79 Chinese hamster c e l l s . Cel ls a re micro- in jec ted 
with* Lucifer yellow. Left panel shows communicating c e l l s . Right panel shows 
non-communicating c e l l s . 
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CHAPTER 
This chapter i s based mainly on the following p u b l i c a t i o n : 
Jongen, W.M.F., Hakkert, B.C. and van der Hoeven, J . C M . (1985), Genotoxici ty 
t e s t i n g of c igare t te-smoke condensate in the SCE and HGPRT assays with V79 
Chinese hamster c e l l s , Fd Chem. T o x i c , 23, 603-607. 
43 
CO-CULTIVATION OF CELLS AS A PRACTICAL TOOL FOR 
MUTAGENICITY TESTING 
ABSTRACT 
The cyto toxic and mutagenic e f f ec t s of B(a)P, DMN, CSC and TP A, compounds from 
d i f fen t chemical c l a s s e s , were i nves t iga t ed in the c o - c u l t i v a t i o n sys t em. 
P la t ing e f f i c i ency , s i s t e r chromatid exchanges (SCEs) and forward mutations a t 
the HGPRT locus were scored. 
Benzo(a)pyrene [B(a)P] and dlmethylnitrosamine (NDMA) were pos i t i ve in both 
assays but only a f t e r metabolic a c t i v a t i o n . Cigarette-smoke condensate (CSC) 
was negat ive in the SCE assay both with and without metabolic a c t i v a t i o n . In 
the HGPRT assay no d i r e c t mutagenici ty of CSC was observed but a f t e r metabolic 
a c t i v a t i o n t he re was a cons iderable increase in the number of mutants. The 
phorboles ter 12-0- te t radecanoylphorbol -13-ace ta te (TPA) was not mutagenic a t 
the concen t ra t ions t e s t e d . Comparison of a number of metabolizing systems, 
showed tha t B(a)P with non-induced, i n t a c t chick hepatocytes induced a com-
parable number of mutants as B(a)P wi th l i v e r from Aroclor 1254 p re t r ea t ed 
r a t s . The chick l i v e r homogenate was considerably l e s s a c t i v e on B(a)P. DMN 
was weakly p o s i t i v e with a l l t h ree systems, the i n t a c t hepatocytes giving the 
h ighes t number of mutants . When CSC was t e s t e d , a l l t h r ee metabolizing systems 
generated s imi l a r numbers of mutants . 
In t h i s study the use of primary chick-embryo hepatocytes showed the bes t 
performance as an a c t i v a t i o n system. The c o - c u l t i v a t i o n system seems to be a 
use fu l , p r a c t i c a l t o o l in mutagenici ty t e s t i n g . 
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INTRODUCTION 
When short term in vitro genotoxicity test systems are used the choice of the 
metabolizing system can critically affect the results. In the majority of 
studies liver homogenates or subcellular liver fractions are used to mimic in 
vivo drug metabolism. Homogenate fractions, however, may give a false 
representation, both qualitatively and quantitatively of the overall biotrans-
formation process occurring in the cells from which they are prepared. The 
subcellular fractions cannot account for rate limiting factors such as uptake 
of chemicals, their intracellular distribution and the release of metabolites 
by the intact cell. In addition, homogenization and fractionation of tissue 
may modify the micro environment. Furthermore, to express their oxydative 
capacity, subcellular preparations are usually equipped with very high, non 
physiological levels of NADPH or NADPH regenerating factors (Brouns, 1981). 
One of the major shortcomings of subcellular preparations is that they lack 
the capacity to carry out sequential reactions like microsomal oxydation 
followed by conjugation. Conjugation reactions catalyzed by enzymes located in 
different cellular compartments and depending on the generation of different 
cofactors are much less operative in these subcellular fractions (Selkirk, 
1977; Bock et al., 1976; Wright, 1980). Despite such restrictions the results 
of in vitro tests using subcellular activation systems are valuable in that 
they provide preliminary indications that a mutagenic agent may pose a geno-
toxic risk in vivo (Wright, 1980). 
In studies directed towards metabolic processes involved in the biotransfor-
mation of premutagens many of the above mentioned disadvantages may be over-
come by the use of intact cells as metabolizing system. Isolated hepatocytes 
resemble in their structural and biochemical properties the in vivo situation 
much more than subcellular fractions (Brouns et al., 1979; Glatt et al., 1981; 
Green et al, , 1977; Jones et al., 1978; Kuroki and Drevon, 1978; Nordenskjöld 
et al, , 1981; Strom et al., 1981). Unfortunately, when mammalian hepatocytes 
are cultured in vitro, the levels of the cytochrome P450 containing mono-oxy-
genases decline fairly rapidly except after addition of hormones or in co-
cultivation with epithelial cells (Holme et al., 1983; Paine, 1980; Malansky 
and Williams, 1982; Quillouzo et al., 1985). In contrast to parenchymal cells 
isolated from mammalian liver, chick-embryo hepatocytes maintain their initial 
levels of cytochrome P450 containing mono-oxygenases in vitro for at least 
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72 h. Moreover induction, both in vivo and in vitro, with known enzyme indu-
cers like phénobarbital, 3 methylcholanthrene or Aroclor 1254 leads to induc-
tion rates comparable with the in vivo situation (Althaus et al., 1979; 
Sinclair et al., 1979; Topp and van Bladeren, 1986). Sofar several studies, 
using primary chick embryo hepatocytes as metabolizing system, have shown that 
these cells are capable of bioactivation of a wide range of premutagens be-
longing to different chemical classes (Hoeven van der et al., 1984; Bruggëman 
and van der Hoeven, 1985; Jongen et al., 1985; 1986). 
The purpose of the study presented in this chapter was twofold. The mutagenic 
effects of the model compounds, selected for the present investigations, were 
studied in the co-cultivation system with two different endpoints, the SCE 
assay and the HGPRT assay. Additionally, the sensitivity of this test system 
was compared with that of two different subcellular homogenates. 
MATERIALS and METHODS 
Materials. Cigarette-smoke condensate (CSC) was prepared according to Groenen 
(1981) and was a gift from the CIVO Institutes TNO, Zeist, The Netherlands. 
Benzo(a)pyrene (B(a)P), which was used as positive control, was obtained from 
Sigma Chemical Co., St Louis, MO, USA. CSC and B(a)P were dissolved in concen-
trations of 8.0 and 2.0 mg/ml, respectively, in dimethylsulfoxide (DMSO) ob-
tained from E. Merck AG, Darmstadt, FRG. 6-thioguanine (6-TG) was obtained 
from Fluka AG Buchs Sg, Switzerland. Eggs containing chick embryos (Hubbard 
strain) were purchased from De Zeeuw, Bennekom, The Netherlands. 
Isolation of primary chick embryo hepatocytes. Hepatocytes were isolated under 
sterile conditions from 15-day-old chick embryos. The procedure followed was 
essentially the same as that described by Debets et al. (1980). In summary, 
the livers were perfused in situ with a Ca- and Mg-free solution of Hanks' BSS 
containing 0.04% EDTA and HEPES (20mM, pH7.4). The livers were removed, trans-
ferred to a Petri dish containing the perfusion solution and sliced in small 
pieces, which were transferred into an Erlenmeyer flask and enzymatically 
dissociated with dispase (2 mg/ml) for 10 min at 37° C. The dissociated cells 
were collected and the remaining liver material was treated with dispase 
again. The cells were pooled, centrifuged (300g for 4min) and resuspended in a 
buffered solution of ammonium chloride to remove erythrocytes. After 4 min the 
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c e l l s were centr i fuged (300g for 4 min), resuspended in Williams E medium 
(supplemented with 10% newborn-calf serum and 2 mM glutamine) and p l a t ed . 
Co-cu l t i va t i on . Five ml of a hepatocyte suspension (6x10^ hepatocytes /ml) were 
p la ted in a 6-cm diameter P e t r i d i sh and incubated a t 37° C in a humidified 
atmosphere containing 5% CC>2- After 4 hr the medium was replaced to remove 
unattached c e l l s . After 24 hr the medium was replaced by Ham's F10, supple -
mented wi th 10% newborn- ca l f serum and lxl0*> V79 Chinese hamster e p i t h e l i a l 
c e l l s were added. 2 hr l a t e r the t e s t compound was added. The t e s t compound 
was removed a f t e r 24 h r , the c e l l s were washed twice wi th phys io logica l s a l t 
so lu t i on , d i s soc i a t ed with t ryps in (0.2%) and suspended in Ham's F10 medium, 
supplemented with 10% newborn-calf serum, p e n i c i l l i n (50 U/ml) and s t r e p t o -
mycin (50 yg/ml) . For the SCE t e s t 1x10^ V79 c e l l s were p la ted onto microsco-
p i ca l s l i d e s , 2.5x10^ c e l l s were t r ans fe r red to t i s s u e c u l t u r e f lasks for the 
HGPRT t e s t and 200 c e l l s were p la ted in 6-cm diameter P e t r i dishes to es t imate 
s u r v i v a l . 
P r e p a r a t i o n of l i v e r homogenates. Rat l i v e r homogenate was prepared from 
3-month-old male Wistar r a t s in jec ted ip with a suspension (200 mg/ml) of 
Aroclor 1254 in o l ive o i l a t a dose of 500 mg/kg body weight. Five days a f t e r 
i n j e c t i o n the animals were anaes the t ized wi th d i e t h y l e t h e r and the l i v e r s were 
perfused with a phosphate buffer (0 .1 M, pH 7 .4 ; O.lmM EDTA) and removed. 
Livers were weighed, cut in to small p i eces , r insed with buffer and t r ans fe r red 
in to a P o t t e r appara tus . After homogenizing in buffer (3ml/g l i v e r ) a t 1200 
rpm the homogenate was centr i fuged for 15 min a t 9000 g. The supernatant (S-9) 
was co l l ec t ed and supplemented with buffer to a t o t a l volume of 4ml/g l i v e r 
and s tored in l iqu id n i t rogen a t -196° C. Liver homogenate was prepared from 
15-day-old chick embryos which were removed from t h e i r s h e l l s and decap i t a t ed . 
The l i v e r s were perfused in s i t u with a Ca- and Mg-free phys io logica l s a l t 
so lu t ion containing EDTA (0.04%) and HEPES (20mM; pH7.4). Prepara t ion of the 
homogenate was as described for r a t l i v e r homogenate. 
P re - incuba t ion assay . A mixture containing 1 ml of c e l l suspension (10" V79 
c e l l s / m l ) , 0.2 ml S-9 mix and 10 y l of the so lu t ion containing the t e s t com-
pound was pre- incubated for 2 hr a t 37° C in a shaking waterhath . After cen-
t r i f u g a t i o n for 4 min a t 300 g the supernatant was discarded and the p e l l e t 
was r e suspended i n a phys io log ica l s a l t so lu t ion containing HEPES (20mM, 
pH7.4). After repea t ing cen t r i fuga t ion the c e l l s were resuspended, counted 
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and the appropriate number of cells was plated to assay plating efficiency, 
SCË induction and HGPRT deficient mutants. The S-9 mix contained 30% S-9 and 
the composition of the co-factors was as described by Ames (1975). 
SCE test. The SCE assay was performed according to Perry & Wolff (1974) with 
slight modifications. Microscope slides were washed in ethanol, sterilized and 
placed in 10-cm diameter Petri dishes. One ml of a cell suspension containing 
1x10^ V79 cells was applied to the slides and incubated for 2 hr for the cells 
to attach. Then 9 ml of medium containing bromodeoxyuridine (11.1 ym) was 
added, the cells were incubated in the dark for 24 hr and subsequently treated 
with colchicine (0.1 yg/ml) for 4 hr. To obtain visible chromosomes the cells 
were washed with Hanks' BSS and allowed to swell in a 75 mM KCl solution for 
15 min at room temperature. Fixation was done in methanol/acetic acid (3:1, 
v/v) followed by air drying overnight. Staining was performed as described by 
Jongen et al. (1981). For each experiment all exposures were carried out in 
duplicate and at each dose level two slides were prepared. On each slide 25 
metaphases were scored. Each experiment was repeated at least once. Because 
the V79 cell line is pseudodiploid the number of SCEs was expressed as the 
number of SCEs/chromosome. 
Gene mutation test at the HGPRT locus. The experiments on forward mutation 
were slight modifications of those described by van Zeeland & Simons (1975 & 
1976a, b). After exposure to various doses of the model compounds, survival 
was measured by seeding 200 cells in a 9-cm diameter Petri dish. After incu-
bation for 7 days the colonies were fixed in methanol, stained in Giemsa and 
counted. Simultaneously with cell seeding for survival 2.5x10^ cells were 
plated and subcultured every second day to maintain a logarithmically growing 
cell population. After an expression time of 7 days, cells were seeded into 
9-cm Petri dishes, ( 10^ cells/dish) in medium supplemented with 6-TG (10 
yg/ml). For estimation of the plating efficiency 200 cells were seeded. Mutant 
selection dishes were incubated for 9 days and plating efficiency dishes for 7 
days before fixation (in methanol), staining (10 min in 10% Giemsa) and coun-
ting of the colonies. Each point was carried out in duplicate. At each dose, 
cells were plated into five dishes. Each experiment was repeated at least 
once. An effect was considered to be positive when the induced mutation 
frequency was at least three times higher than the spontaneous mutation frequ-
ency for that specific experiment (Bradley et al., 1981). 
48 
RESULTS 
The data on survival of the V79 cells after exposure to the selected 
compounds, with and without the presence of different metabolizing systems, is 
presented in Table I. Because DMSO was used as solvent different concentra-
tions of this compound were also tested. Concentrations of 3% and higher 
appeared to be cytotoxic and therefore in subsequent experiments the concen-
tration of DMSO did not exceed 1%. Without metabolic activation only the 
highest concentration of CSC tested (64 yg/ml) showed cytotoxic effects 
whereas after metabolic activation, irrespective of the system, all concen-
trations applied showed some cytotoxic effects. However no dose response-
relationship was observed in any of the three metabolizing systems. For B(a)P 
differences in survival were observed between the different metabolizing sys-
tems. The largest decrease in plating efficiency was found in the presence of 
primary chick-embryo hepatocytes whereas the smallest decrease was observed in 
the presence of liver homogenate, prepared from the same chick embryos. For 
NDMA the primary chick-embryo hepatocytes gave a comparable reduction in sur-
vival as the rat-liver homogenate. Again the liver homogenate prepared from 
chick embryos gave the smallest reduction in survival. When the phorbolester 
TPA was tested no cytotoxic effects were observed with or without the presence 
of metabolizing systems. CSC at concentrations up to 64 yg/ml does not induce 
mutants on the HGPRT locus in V79 cells without metabolic activation (Table 
II). However after metabolic activation there was a dose related increase in 
the number of mutants, and the increase was similar in each of the metaboli-
zing systems. In contrast, for B(a)P there were considerable differences 
between the metabolizing systems with regard to the number of mutants induced: 
the chick-liver homogenate induced a substantially smaller number of mutants 
than did the two other systems Therefore the observed cytotoxicity of B(a)P 
seemed to be reflected in the number of mutants. Also for NDMA there appeared 
to be differences. In the presence of rat-liver homogenate no mutagenic 
effects were observed. Chick-liver homogenate induced a borderline increase in 
the number of mutants. The only clear-cut positive results were obtained when 
primary chick-embryo hepatocytes were used. No positive effects were observed 
when TPA was tested either with or without different metabolizing systems. In 
the SCE test a small increase was observed in the number of SCEs in V7 9 cells 
after exposure to CSC in the co-cultivation system with primary chick-embryo 
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Table I. Survival of V79 Chinese hamster cells after exposure to various 
compounds without metabolic activation and after activation with 
different metabolizing systems. 
PLATING EFFICIENCY (%) 
activation with: 
Exposure no activation Hepatocytes Chick S-9 Rat S-
Control 
DMSO 
(Ml/ml) 
CSC 
(/ig/ml) 
B(a)P 
(/jg/ml) 
DMN 
(pg/ml) 
TPA 
(ng/ml) 
10 
30 
50 
16 
24 
32 
64 
1.0 
10.0 
1000 
1500 
2000 
10 
50 
100 
1000 
94 
98 
84 
46 
nt 
nt 
96 
79 
nt 
nt 
nt 
nt 
nt 
96 
95 
97 
95 
93 
93 
nt 
nt 
87 
73 
72 
82 
55 
17 
81 
39 
32 
99 
95 
97 
95 
100 
99 
nt 
nt 
nt 
nt 
77 
73 
95 
73 
87 
80 
77 
95 
92 
96 
97 
95 
94 
nt 
nt 
78 
nt 
73 
66 
92 
39 
70 
45 
37 
95 
100 
96 
94 
nt= not tested. DMSO-dimethylsulfoxide CSC= cigarette-smoke condensate 
B(a)P- benzo(a)pyrene DMN- dimethylnitrosamine TPA= 12 O-tetradecanoylphorb-
ol-13-acetate. Survival is based on 200 cells/plate. Values are means of 
duplicate tests. Exposure without activation and with co-cultivation with 
primary chick-embryo hepatocytes was for 24 hr. Exposure with preincubation 
with rat or chick-embryo S-9 was for 2 hr. 
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Table II. Mutagenicity of various compounds in the HGPRT assay with V79 
Chinese hamster cells without metabolic activation and with 
activation with different metabolizing systems. 
MUTAGENICITY (mutants/105 survivors) 
activation with: 
Exposure 
Control 
DMSO 
(Ml/ml) 
CSC 
(/ig/ml) 
B(a)P 
(/ig/ml) 
DMN 
(Mg/ml) 
TPA 
(ng/ml) 
10 
16 
24 
32 
64 
1.0 
2.5 
5.0 
10.0 
1000 
1500 
2000 
10 
50 
100 
1000 
no activation 
1.6+0.6 
1. 7±0.8 
nt 
nt 
2.7±1.0 
2.6±0.7 
nt 
nt 
nt 
nt 
nt 
nt 
nt 
1.4+0.3 
2.1±0.5 
2.3±1.1 
1.9±0.9 
Hepatocytes 
1.6±0.5 
1.7±0.7 
6.8±1.3 
7.1±1.1 
11.9±1.8 
16.3±1.1 
12.2±1.8 
19.7±2.1 
30.1+3.0 
48.6±4.7 
3.4+0.8 
6.9±0.6 
7.3+1.6 
2.3±1.1 
1.9±0.9 
3.2±1.3 
2.4±1.2 
Chick S-9 
1.2±0.7 
1.5±0.3 
nt 
nt 
6.5+1.5 
14.310.9 
3. 7±1.1 
nt 
nt 
13.5+1.9 
1.0±0.2 
1.5±0.5 
3.4±1.4 
1.5±0.6 
1.4+1.0 
3.0±0.9 
2.511.0 
Rat S-9 
1.5+0.4 
1.610.6 
nt 
nt 
8.911.4 
16.2+1.9 
9.4+2.1 
nt 
nt 
41.913.2 
2.5±0.7 
2.711.1 
3.110.6 
0.810.1 
2.010.7 
1.710.3 
2.110.9 
nt= not tested. DMSO- dimethylsulfoxide ; CSC= cigarette-smoke condensate; 
B(a)P= benzo(a)pyrene; DMN- dimethylnitrosamine; TPA= tetradecanoylphorbol-
acetate. Values are means (1SEM) of duplicate tests. Exposure without acti-
vation and with co-cultivation with primary chick-embryo hepatocytes was for 
24 hr. Exposure with rat and chick-embryo S-9 was for 2 hr. 
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Table III. Induction of sister chromatid exchanges in V79 Chinese hamster 
cells by various compounds without metabolic activation and after 
co-cultivation with primary chick-embryo hepatocytes. 
SCEs/CHROMOSOME 
Exposure No activation Co-cultivation 
Control 
DMSO 
(Ml/ml) 
CSC 
(/ig/ml) 
B(a)P 
(pg/ml) 
DMN 
(/xg/ml) 
TPA 
(ng/ml) 
10 
16 
24 
32 
64 
1.0 
2.5 
5.0 
10.0 
1000 
1500 
2000 
10 
50 
100 
1000 
0.27±0.01 
0.27±0.03 
0.35±0.02 
nt 
0.38+0.02 
0.41±0.04 
nt 
0.30+0.03 
nt 
0.28+0.02 
0.23±0.02 
0.24+0.03 
0.28±0.03 
0.28±0.01 
0.28±0.03 
0.24+0.03 
0.24±0.03 
0.26±0.01 
0.25±0.03 
0.39±0.04 
0.36±0.05 
0.38±0.05 
0.41±0.04 
0.34+0.03 
0.80±0.03 
0.96+0.03 
1.21±0.06 
0.88+0.07 
1.74+0.07 
2.73±0.11 
0.25±0.02 
0.25±0.03 
0.27±0.02 
0.23±0.04 
SCE= sister chromatid exchange; DMS0= dimethylsulfoxide ; B(a)P= benzo(a)pyrene 
DMN- dimethylnitrosamine; TPA= 12-0-tetradecanoylphorbol-13-acetate. Values 
are means (±SEM) of duplicate tests. The cells were exposed to the test com-
pounds for 24 hr. 
hepatocytes (Table III). Without metabolic activation the same increase was 
observed. Furthermore there is no dose- response relationship. Exposure to 
B(a)P and DMN induced a considerable increase in the number of SCEs. Also in 
the SCE test TPA did not generate any positive effect with or without meta-
bolic activation. 
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DISCUSSION 
The genotoxicity of CSC has been studied using V79 Chinese hamster cells in 
two test systems with different endpoints. In the HGPRT test a clear positive 
effect was found after metabolic activation with any one of the three metabo-
lizing test systems: co-cultivation with primary chick-embryo hepatocytes, 
preincubation with S-9 prepared from rat or chick-embryo livers. No clear 
differences in mutagenic or cytotoxic effects were observed between the dif-
ferent metabolizing systems. A small increase in the number of SCEs was obser-
ved after exposure to CSC irrespective of metabolic activation (co-cultivation 
with primary chick-embryo hepatocytes). The increase was consistent in all 
experiments but never exceeded 40%. This raises the question whether it is 
justified to ascribe this positive effect to a reaction of CSC with the DNA of 
the cells. 
Firstly, no influence of biotransformation on the number of SCEs has been 
observed in the present or other (De Raat, 1979) studies. This is in contrast 
with the data obtained with the Salmonella/mammalian microsome assay 
(DeMarini, 1983) and the HGPRT test (Clive et al., 1979) in which positive 
effects were only obtained with metabolic activation. Secondly, no dose-res-
ponse relationship was found. Finally, the concentrations of CSC used in this 
study also show cytotoxic effects and it is possible that toxic effects in-
fluence the cell cycle and thus cause an increase in the number of SCEs 
(Jongen et al., 1981). Comparison of our data with those reported in the lite-
rature shows that although De Raat et al.(1979) found an increase in the num-
ber of SCEs the higher concentrations of DMSO used in that study are cytotoxic 
and may have a considerable influence on the number of SCEs. Hopkin & Evans 
(1979) did find positive effects of CSC on the induction of SCEs in human 
lymphocytes in vitro. These results were confirmed by other studies (Madle 
etal., 1981; Sorsa et al., 1982; Vijayalaxml & Evans, 1982). Possibly the 
metabolizing capacity of the lymphocytes plays an essential role. When the 
results of the different metabolizing systems are compared for B(a)P, Aroclor 
1254 pretreated rat-liver homogenate induces a comparable number of mutants as 
non-induced primary chick-embryo hepatocytes. S-9 prepared from chick-embryo 
liver is much less active in inducing mutants than the intact cells. One pos-
sible explanation for this difference is, that due to the stability of the 
metabolizing system in vitro, longer exposure times can be applied with the 
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intact cells. Rat-liver homogenate appeared to be able to metabolise DMN to 
cytotoxic intermediates as can be seen in the survival data. However, in con-
trast to the results obtained with primary chick-embryo hepatocytes, these 
effects were not reflected in the mutagenicity data. No significant increase 
in the number of mutants was observed. When the data, obtained with systems 
derived from chick-embryo were compared, the use of intact liver cells 
appeared to generate a higher number of mutants than the liver homogenate. For 
both endpoints used no effect of TPA was observed. In the literature conflic-
ting data on the induction of SCEs by TPA have been reported. Some laborato-
ries found an increase in the number of SCEs (Kinsella and Radman,1978; Gentil 
et al., 1980; Nagasawa and Little, 1979) but others did not observe such 
effects (Loveday and Latt, 1977; Thompson et al., 1980). The apparent contra-
diction in observed effects can be ascribed to the presence of the enzyme 
superoxide dismutase (SOD) in the serum of the culture medium. If the enzyme 
is present in sufficient amounts it prevents the interaction of superoxide 
radicals, formed by interaction of TPA with the cellular membrane, with the 
DNA of cells (Nagasawa and Little, 1981; Yamasaki, 1985). 
In conclusion, we have demonstrated that CSC, B(a)P and DMN are positive in 
the HGPRT assay with V79 cells after metabolic activation but that CSC, in 
contrast to B(a)P and DMN, is negative in the SCE assay after metabolic 
activation in a co-cultivation system with primary chick-embryo hepatocytes. 
These results suggest that the SCE assay with V79 cells does not offer an 
adequate endpoint for measuring the genotoxic properties of this complex 
mixture. The use of intact hepatocytes, compared with subcellular fractions, 
offers a more sensitive test system for the compounds selected in this study. 
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TRANSPORT OF REACTIVE INTERMEDIATES IN A 
CO-CULTIVATION SYSTEM: 
THE ROLE OF METABOLIC COOPERATION 
ABSTRACT 
The t r anspor t of r e ac t i ve in te rmedia tes from primary chick-embryo hepatocytes 
to V79 Chinese hamster c e l l s was inves t iga ted using two t e s t systems with 
d i f f e r e n t gene t ic endpoints (SCE and HGPRT a s s a y ) . When the V7 9 c e l l s were 
co -cu l t i va t ed with the hepatocytes a t a d i s tance of 1 mm, t h e mu tagen ic 
e f f e c t s of B(a)P were reduced wi th ca . 75% compared wi th the normal c o - c u l t i -
vat ion cond i t i ons , in which there i s d i r e c t c e l l - c e l l contact between primary 
chick-embryo hepatocytes and V79 c e l l s . Addition of TPA and CSC inh ib i t ed the 
mutagenic e f f ec t s of B(a)P in both assays with 50% when the two c e l l types 
were in d i r e c t con t ac t . No in f luence of TPA on the number of B(a)P induced 
SCEs was observed in a p re - incuba t ion assay using Aroclor 1254 p r e t r e a t e d r a t 
l i v e r homogenate. CSC appeared to be able to i n h i b i t metabolic cooperat ion 
between V79 c e l l s . When the t r a n s p o r t s t u d i e s were done with the metabol ic 
cooperat ion d e f i c i e n t mutant V79 c e l l l i n e MC~-27, in add i t i on to B(a)P, a lso 
DMN was used. The i n h i b i t o r y e f f ec t s of TPA on wild type V79 c e l l s were com-
p l e t e l y comparable to those obtained wi th the mutant c e l l l i n e . No d i f f e rence 
in i n t r i n s i c s e n s i t i v i t y for mutagenic e f f ec t s was found between the V79 wild 
type c e l l s and the V79 MC~-27 c e l l s . The r e s u l t s s t rongly suggest the occur-
rence of t r anspo r t of r e ac t i ve in te rmedia tes in t h i s c o - c u l t i v a t i o n system and 
the involvement of metabolic cooperat ion pathways in t h i s t r a n s p o r t . 
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INTRODUCTION 
In the field of mutagenicity testing liver homogenates or subcellular liver 
fractions are commonly used to mimic in vivo metabolism. For several reasons, 
indicated in the previous chapter, results obtained with these homogenates and 
fractions may not be representative either qualitatively or quantitatively for 
the overall biotransformation process in intact cells (Wright, 1980). To 
avoid several of these disadvantages, systems have been developed which make 
use of intact cells as metabolizing system. Also when cell-mediated metabolic 
activation is used interpretation of mutagenicity data obtained with these 
systems may be complicated. In principle the transport of reactive inter-
mediates may take place via two routes, namely via cell-cell contact where gap 
junctions act as gates or via the medium. 
In case of transport through the medium the cellular membrane of the metaboli-
zing cell will represent an additional barrier for the reactive intermediates 
to reach DNA of target cells (Brouns et al., 1979; Glatt et al., 1981). Also 
the composition of the culture medium, such as for instance the type and 
amount of serum, may interfere with the transfer of these metabolites (Kuroki 
and Drevon, 1978). In all studies published to date it is generally assumed 
that in cell-mediated metabolism the transport of reactive intermediates 
occurs through the medium. 
The existence of gap junctions between homologous and heterologous cells has 
been shown by several authors (Epstein and Gilula, 1977; Hooper, 1982; Hunter 
and Pitts, 1981). The presence of these junctions permits the free exchange 
between cells of small molecules and ions but not of macromolecules (Simpson 
et al., 1977).This suggests that also (metabolites of) xenobiotics will be 
transported in this way. Compounds effecting cellular membranes are known to 
influence the transfer of molecules from one cell to neighbouring cells. 
Several tumor-promoting compounds, especially the phorbolesters, inhibit 
metabolic cooperation between cells (Trosko and Chang, 1983; 1984). 
The aim of the study presented in this chapter was to investigate the trans-
port of reactive intermediates. This includes experiments on the route of 
transport of active metabolites from B(a)P and DMN. The role of transport of 
metabolites through gap junctions was studied by the use of TPA and the meta-
bolic cooperation deficient mutant cell line MC~-27. 
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MATERIAL and METHODS 
Material 
The phorboles te r 12-0- te t radecanoylphorbol -13-ace ta te (TPA) was obtained from 
Dr Peter Borcher t , Chemical Carcinogenesis I n s t i t u t e , Eden P r a i r i e , HN 55344, 
U.S.A. Al l o ther compounds were obtained as described under M.& M. in chapter 
I I I . 
Methods 
Test of i n h i b i t i o n of metabolic cooperat ion 
The t e s t p ro toco l for t h i s assay was a modified vers ion of t ha t described by 
Yo t t i e t a l . ( 1 9 7 9 ) : 2x l0 5 6-TG s e n s i t i v e V79 c e l l s toge the r with 200 6-TG r e -
s i s t a n t V79 c e l l s were p la ted in 6-cm diameter P e t r i d ishes in r e p l i c a t e s of 
f i v e . After 18 hr the t e s t compound was added and 30 min l a t e r 6-TG (10 yg/ml) 
was added. Seventy-two hours a f t e r app l i c a t i on of the t e s t compound the medium 
was replaced and 7 days a f t e r p l a t i ng the colonies were f ixed( in methanol) 
s ta ined (10 min in 10% Giemsa) and counted. I n h i b i t i o n of metabolic coopera-
t i o n was expressed as the d i f fe rence in percentages between the number of 
colonies grown with and without app l i c a t i on of the t e s t compound and cor rec ted 
for the spontaneous mutation frequency of the 6-TG-sensi t ive c e l l s . Each t e s t 
was repeated a t l e a s t once. 
I s o l a t i o n of metabolic cooperat ion d e f i c i e n t mutants of Chinese hamster V7 9 
c e l l s 
A non- reve r t ab le 6 - t h i o g u a n i n e - r e s i s t a n t (6TGr) mutant c e l l l i n e of Chinese 
hamster V79 c e l l s (380-23), obtained from Dr. E.H.Y. Chu of the Univers i ty of 
Mich igan , was mutagenized by a combined t reatment of 5-bromodeoxyuridine 
(10_4M for 1 day) and black l i g h t (90 min) (Chu e t a l . , 1972). The surviving 
colonies developed in a week were rep la ted and i r r a d i a t e d by UV l i g h t (10 
J/M^). These mutagenized 6 TGr c e l l s were se lec ted four times by 6- thioguanine 
(20 pg/ml) i n the presence of high dens i ty of wild type 6-TGs c e l l s . The c e l l 
numbers per p l a t e (9cm) were 5x l0 4 6-TGr and 2x l0 6 6-TGs c e l l s i n the f i r s t 
two s e l e c t i o n s , 1x10^ 6-TGr and 5xl0 6 6-TGs c e l l s in the t h i r d s e l e c t i o n and 
400 6-TGr and 5x l0 6 6-TGs c e l l s i n the four th s e l e c t i o n . After the l a s t s e l e c -
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tion, 28 surviving 6-TGr colonies were randomly selected and tested for their 
abi l i ty to metabolically cooperate with 6-TGs ce l l s . The resul ts indicate that 
a l l these clones except one are deficient in metabolic cooperation. Seven most 
deficient clones were further tested and confirmed as deficient in metabolic 
cooperation. One of these clones, MCT-27, was used for experiments in th is 
report. The isolation of the mutant cel l line was performed by Dr. C.C. Chang, 
East Lansing, Michigan, USA. 
Determination of i n t e r c e l l u l a r communication by scrape-loading and dye 
transfer 
The method recently developed by El-Fouly et a l . (1987) was used. The ce l l 
monolayer was plated overnight and rinsed with phosphate buffered saline (PBS) 
before the addition of Lucifer yellow (0.05% in PBS). The dye solution was 
scrape-loaded at room temperature using a metal or wooden probe and left on 
the cells for 3 minutes before i t was decanted. The plates were then rinsed 
with PBS to remove the background fluorescence and the cel ls examined for 
Lucifer yellow transfer under a Nikon epifluorescence phase microscope illumi-
nated with an Osram HBO 200 W lamp. 
Exposure at a distance 
Primary chick-embryo hepatocytes were plated in 9-cm diameter Petr i dishes 
(6x10" c e l l s / d i s h ) . Simultaneously, 5x10^ V79 Chinese hamster cells were 
plated onto microscopical sl ides and incubated overnight. The next day, 1 
mm-thick pieces of glass were placed in the dishes containing the hepatocytes 
and the slides carrying the V79 cel ls were placed on top of these glass pieces 
with the V79 cells directed towards the hepatocytes. After exposure the V7 9 
cel ls were dissociated with trypsin, collected and treated as described for 
the SCE assay. Exposure conditions were identical as described for co-cultiva-
tion. 
All other methods are described in chapter I I I 
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RESULTS 
First of all, the question whether direct or proximate contact between the 
hepatocytes and the V79 cells is necessary for an adequate transfer of reac-
tive intermediates was studied. The induction of SCEs by B(a)P using co-culti-
vation was compared with a system in which the two cell types were kept sepa-
rate. The data in Table I show that when the two cell types are kept at a 
distance of 1 mm the number of SCEs is considerably lower. This indicates that 
direct or proximate contact between the two cell types is required for ade-
quate genotoxicity measurement. 
Table I The effect of cell distance on the mutagenicity of B(a)P in a co 
cultivation system consisting of primary chick-embryo hepatocytes 
and V79 Chinese hamster cells. 
Exposure SCEs/chromosome 
B(a)P (ug/ml) co-cultivation At distance of 1 mm 
0 
2.5 
5.0 
7.5 
0.2510.02 
0.67+0.04 
0.82±0.04 
1.2110.06 
0.3010.03 
0.4110.05 
0.4310.04 
0.5510.02 
Data represent mean ± SEM. Experiments carried out in triplicate. 
TPA is a well known tumor promoter and it is known to inhibit metabolic 
cooperation between cells. When different concentrations of this phorbolester 
were added to the co-cultivation system, 30 min before the cells were exposed 
to B(a)P an increasing dose of TPA caused a dose-related decrease in the 
number of SCEs (Fig I). TPA itself had no effect on the number of SCEs in V7 9 
cells at concentrations up to 5 yg/ml (data not shown). 
Comparison of the HGPRT assay and the SCE assay showed that for both genetic 
endpoints approximately the same percentage of inhibition was found (Table 
ID-
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Figure I: Inhibitory effects of TPA on B(a)P induced SCEs in a co-cul-
tivation system consisting of primary chick-embryo hepatocytes 
and V79 Chinese hamster cells. 
B(Q) P (10 p.g/ml 
og [TPA(^g/ml)] 
Control value has been subtracted (0.27±0.03). Values are given with their 
S.E.M. 
CSC did inhibit B(a)P-induced mutagenicity in both assays when tested in the 
co-cultivation system. If the inhibitory effect in the HGPRT assay is cor-
rected for the mutagenicity of the mixture itself, the inhibition is quan 
titatively comparable with that caused by TPA. Of course this does not imply a 
qualitative equivalence between TPA and CSC since the doses differ by 
300-fold. 
Because these data indicated that CSC was capable of inhibition of metabolic 
cooperation the effects of this complex mixture on metabolic cooperation 
between V79 cells was studied. The data are presented in Figure II and show 
that at nôn-cytotoxic doses a dose related increase in the number of surviving 
colonies was found, indicating that CSC indeed inhibits metabolic cooperation 
between cells. 
65 
Table II Inhibitory effects of TPA and CSC on B(a)P induced mutagenicity 
in a co-cultivation system consisting of primary chick-embryo 
hepatocytes and V79 Chinese hamster cells. 
B(a)P CSC TPA HGPRT assay SCE assay 
Survival (%) Mutants/105 survivors SCEs/chromosome 
-
-
+ 
-
+ 
+ 
-
+ 
+ 
-
-
-
-
-
-
+ 
+ 
-
97 
87 
67 
101 
71 
20 
2.1±0.6 
12.3±1.9 
43.9±2.0 
2.2±0.7 
29.3+1.6 
67.0+2.6 
0.27±0.04 
0.40±0.04 
0.65±0.06 
0.27±0.02 
0.69+0.07 
1.01±0.07 
Exposure to the various compounds was: B(a)P: 10 /jg/ml; CSC:32 pg/ml; TPA:0.1 
jig/ml. Data are means of duplicate tests and are given with their SEM. 
To find out whether non-specific membrane effects play a significant role in 
the inhibitory effect of TPA, a suspension of V79 cells was exposed to B(a)P 
in a preincubation assay. In this situation metabolic cooperation is not pos-
sible. After addition of TPA no significant difference in the number of SCEs 
was observed (Table III) 
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Figure II: Influence of cigarette-smoke condensate on the metabolic coope-
ration between 6-TG resistant and 6-TG sensitive V79 Chinese 
hamster cells. 
recovery (%) 
100-1 
50 
0 
TPA(0.1pg/ml] 
0 0 4.5 8 16 
CSC (^g/ml) 
For each dish 200 6-TG resistant and 4x10^ 6-TG sensitive cells were plated. 
The recovery was calculated on the basis of 100% plating efficiency for the 
6-TG resistant cells. The plating efficiency of the 6-TG sensitive cells was 
95%. Values are means of five replicates for one representative experiment and 
are given with their SD. 
Table III Mutagenicity of B(a)P in a preincubation assay with V79 wild type 
cells with and without addition of TPA and MC"-27 cells. 
Exposure 
B(a)P (/ig/ml) 
V79 Wild Type 
TPA (0.1 /Jg/ml) 
V79 MC"-27 
0 
2.5 
5.0 
0.26±0.03 0.25+ .02 0.20±0.04 
0.58+0.04 0.60±0.03 0.62±0.03 
0.75+0.04 0.76+0.04 0.72±0.05 
Data are means of duplicate tests and are given with their SEM 
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The inhibitory effects were strongly related to the culture time of the cells 
(Fig. III). After 6 hr of co-cultivation a significant increase in the percen-
tage of inhibition was observed. The percentage gradually increased with 
longer culture times until a maximum of ca. 50% inhibition was reached after 
24 hr. Upon longer culture times no further increase was observed. 
The MC~-27 Chinese hamster V79 cell mutant was found to be deficient in 
metabolic cooperation (Table IV). 
Figure III: Effect of culture time on the occurrence of transport of reactive 
intermediates through gap junctions formed between primary chick 
embryo hepatocytes and V79 Chinese hamster cells. 
inhibition (%) 
100-
75-
50-
25 
24 48 
time (h) 
Data are calculated from the average values of different experiments carried 
out in duplo. Control values ranged between 0.21-0.25 SCEs/Chromosome. The 
percentage inhibition was calculated after subtraction of the appropriate 
control values. 
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Table IV Metabolie cooperation between 6-TGr and 6-TGs Chinese hamster 
cells. 
6-TGr cells 6-TGs cells Relative recovery of 6-TGr cells (%) 
MC+: 
500 0 100 
500 5xl05 30 
500 lxlO6 10 
500 2xl06 2.4 
MC"-27: 
500 0 100 
500 5xl0 5 98 
500 lxlO 6 88 
500 2xl0 6 89 
6-Thioguanine was added a t a concent ra t ion of 20 /ig/ml. Cel l s were co-cu l tu red 
in 9-cm diameter P e t r i d ishes for seven days. 
The defect in i n t e r c e l l u l a r communication of t h i s c e l l l i n e was fu r ther con-
firmed by an experiment using the scrape- loading and f luorescent dye" t r a n s f e r 
t e c h n i q u e . As shown in Fig. IV, the f luorescen t Lucifer yellow stayed in 
i n i t i a l l y loaded MC~-27 c e l l s i n c o n t r a s t to wild type MC*" c e l l s which t r a n s -
fer Lucifer yellow from i n i t i a l l y loaded c e l l s to contiguous ne ighbour ing 
c e l l s . 
The t r anspor t of r e ac t i ve in te rmedia tes was a lso s tudied wi th the metabolic 
cooperat ion d e f i c i e n t mutant V79 c e l l l i n e MC~-27. To extend the observa t ions 
done sofar to a compound from a d i f f e r en t chemical c l a s s a lso the mutagenici ty 
of dimethylni t rosamine (DMN) was s tud i ed . At d i f f e r en t time poin ts a f t e r s t a r t 
of the c o - c u l t i v a t i o n , the mutagenici ty of B(a)P and DMN in the V79 wild type 
c e l l s with and without add i t i on of TPA was compared wi th the e f f e c t s in the 
MC~-27 c e l l s (Table V). 
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Table V Induction of SCEs by B(a)P and DMN In V79 wild type cells and V79 
MC"-27 cells with and without addition of TPA after cocultivation 
with primary chick-embryo hepatocytes. 
SCEs/CHROMOSOME 
TPA(100 ng/ml) 
Exposure time WT(*) MC-"27(**) WT(*) MC"-27(**) 
Control 24 hr 0.19±0.02 0.21+0.03 0.22±0.02 nt 
B(a)P 0.8310.04 0.52+0.05 0.4310.04 0.41+0.03 
(7.5 /ig/ml) 
DMN 0.88±0.11 0.39±0.07 0.42+0.09 nt 
(1.0 mg/ml) 
Control 48 hr 0.20±0.02 0.24+0.02 0.23±0.02 nt 
B(a)P 
(7.5 /ig/ml) 
DMN 
1.19+0.10 0.70±0.06 
1.24+0.11 0.78+0.11 
0.67±0.04 
0.7610.12 
0.7010.05 
*) - Wild Type. (**) = Metabolic Cooperation deficient mutant cell line. Data 
are mean 1 SEM. Experiments carried out in triplicate. Exposure to B(a)P and 
DMN was for 4 hr. 
The inhibitory effects of TPA were completely comparable to those obtained 
with the mutant cell line. Addition of TPA to the MC"-27 cells had no in-
fluence on the number of SCEs. In addition preincubation experiments were 
performed to compare the intrinsic sensitivity of the two cell lines for the 
mutagenicity of B(a)P. No difference in mutagenic effect, measured as 
SCEs/chromosome was observed (Table III). When different culture times were 
compared the overall mutagenic effects were higher after 48 hr. However no 
difference was observed in the percentage of inhibition between the two cul-
ture times for both compounds. Apparently the amount of reactive intermediates 
transported through gap junctions is proportional to the total amount formed. 
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Figure IV: Photographs of Chinese hamster V79 cells showing positive dye 
transfer in wild type MC+ cells (A) and absence of dye transfer 
in MC-27 cells (B). Cells in the same area were photographed 
under regular (bottom) or fluorescent light (top). 
DISCUSSION 
When the number of induced SCEs in different experiments are compared at equal 
dose levels of B(a)P considerable differences are observed. However within 
each experiment pooled cell suspensions were used and the data between repli-
cates were consistently identical. This discrepancy may be due to quantitative 
differences in the metabolic capacity of the freshly isolated chick-embryo 
hepatocytes. The data presented in this study strongly suggest a significant 
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role of metabolic cooperation in the transfer of reactive intermediates in 
this co-cultivation system. Several other studies have also implicated gap 
junctional communication in the toxicity of polycyclic aromatic hydrocarbons 
(Reiners and Herlick, 1985; Jongen et al., 1986, 1987; Moore et al., 1986; 
Madie et al., 1987). The mutagenic potential of compounds may be underestima-
ted if the compounds or their metabolites are capable of inhibiting metabolic 
cooperation. The finding that CSC inhibits metabolic cooperation between cells 
may be an important factor in the quantification of the mutagenicity data 
obtained with this mixture. Probably, the number of mutants observed in the 
HGPRT assay does not reflect quantitatively the mutagenic potential of CSC 
after activation by intact primary chick-embryo hepatocytes. This may explain 
why for CSC in the HGPRT test no difference in mutagenicity between the three 
metabolizing systems was observed whereas for B(a)P considerable differences 
were observed, depending on the type of system used (Chapter I). 
The mutagenic effects of B(a)P and DMN are reduced by approximately 50% when 
metabolic cooperation between the two cell types is inhibited. Still metabo-
lites appear to be able to penetrate the cellular membranes causing mutagenic 
effects in V79 cells. It is known that depending of the type of metabolite 
formed, intermediates may be selectively retained by the hepatocytes (Jones et 
al., 1978). For both compounds examined, transport occurred through the 
heterologous gap junctions. The proportion of the mutagenic metabolites going 
through the gap junctions was the same for both compounds and independent of 
the total amount of metabolites formed. 
Therefore a preliminary conclusion may be that this type of transport is not 
restricted to specific types of ultimate mutagens but is a phenomenon of a 
more general nature. This observation may have consequences as to which cells 
in a given tissue are at risk to become 'neoplastic' upon exposure to an 
initiating agent. For example, when the V79 epithelial cells are co-cultivated 
with primary chick embryo hepatocytes and then exposed to 10 yg/ml B(a)P, the 
toxicity measured as plating efficiency, results in 80% cell death (Jongen et 
al., 1985; 1986). On the other hand when the metabolism of B(a)P is studied, 
the same hepatocytes are capable of metabolizing concentrations up to 50 yg/ml 
without biochemical or morphological signs of intoxication (Topp and van 
Bladeren, 1986). Thus drug metabolizing cells like the primary chick-embryo 
hepatocytes are protected more efficiently against toxic intermediates than 
non-metabolizing cells like the V79 cells. The finding that reactive inter-
mediates of both B(a)P and DMN are transported through gap junctions suggests 
that under these circumstances they do not inhibit metabolic cooperation. Both 
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Compounds are considered to be initiating carcinogens in animal studies. 
Inhibition of metabolic cooperation has been postulated as an essential step 
in tumor promotion by several authors (Trosko and Chang, 1984; Yamasaki, 
1984a; Yamasaki et al., 1984b). One possible explanation for this apparent 
discrepancy is that the concentrations at which these compounds exert carcino-
genic effects in animals are cytotoxic at a cellular level (Frey, 1976; Trosko 
and Chang, 1981). Probably these cytotoxic effects induce mitogenic stimuli in 
vivo. 
Tachikawa et al. (1986) have reported that dimethylbenzanthracene (DMBA) did 
cause a decrease in both gap junctional communication and in gap junctions in 
cultured primary lingual epithelium as measured by electrophysiological and 
freeze fracture studies, respectively. However, since cell viability studies 
were not conducted, one can not conclude that DMBA modulated gap junctions 
under non-cytotoxic conditions. 
In contrast to these findings other groups have not seen any inhibition of 
metabolic cooperation by complete carcinogens (Noda et al., 1981; Telang et 
al., 1982; Enomoto et al., 1981). Possibly the cell types applied in these 
studies were not capable to metabolize these carcinogens efficiently. 
In conclusion it can be stated that the combined use of the wild type V79 
cells and the MC~-27 cells in co-cultivation with primary chick embryo hepato-
cytes provides a potential promising in vitro model to study the role of gap 
junctional intercellular communication in the transport of reactive interme-
diates. 
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CHAPTER V 
This chapter is based mainly on the following publication: 
Jongen, W.M.F., Sijtsma, S.R., Zwijsen, R.M.L. and Temmink, J.H.M., (1987), 
A co-cultivation system consisting of primary chick-embryo 
hepatocytes and V79 Chinese hamster cells as a model for metabolic 
cooperation studies, Carcinogenesis, 9, 767-772. 
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CO-CULTIVATION OF PRIMARY CHICK-EMBRYO HEPATOCYTES 
AND V79 CHINESE HAMSTER CELLS AS A MODEL FOR 
METABOLIC COOPERATION STUDIES 
ABSTRACT 
In this chapter the role of metabolic cooperation was investigated in a co-
cultivation system consisting of primary chick-embryo hepatocytes and V7 9 
Chinese hamster cells. A morphological study showed that, in addition to the 
gap junctions formed between homologous cells, also gap junctions were formed 
between the primary chick-embryo hepatocytes and the V79 Chinese hamster 
cells. The number of gap junctions present in this system decreased in the 
following order: hep.-hep.> V79-V79> hep.-V79. Under control conditions this 
number was constant during a co-cultivation period of 48 hr. The heterologous 
gap junctions allowed the passage of [^ H] labeled hypoxanthine. Addition of 
the phorbolester TPA inhibited this transfer in a dose related way. Electron 
microscopy studies with sectioned material showed that inhibition of transfer 
was parallelled by the disappearance of all gap junctions. There was a re-
markable difference between the response time of the different types of gap 
junctions. Those formed between V79 cells had disappeared after 20 min, 
whereas those formed between the hepatocytes had disappeared after 12 hr. The 
heterologous gap junctions behaved more or less like those between hepato-
cytes. After exposure times longer than 7 hr the transfer of [^ H] hypoxan-
thine was restored partly and also morphologically the gap junctions 
reappeared. Studies with Mitomycine C indicated that this adaptation may be 
ascribed to the mitotic index of the cells. Cigarette-smoke condensate, which 
is also an inhibitor of intercellular communication did not reduce the number 
of gap junctions. Dimethylbenzanthracene, at non-cytotoxic concentrations, 
inhibited the transfer of labeled nucleotides and may be the first example of 
an indirect acting inhibitor of intercellular communication. 
INTRODUCTION 
The mechanisms underlying the process of tumor promotion are not well under-
stood as yet. Phorbolesters, especially 12-0 tetradecanoylphorbol-13-acetate 
(TPA) have been widely used to study the mechanisms of tumor promotion. These 
esters exert an extraordinarily wide range of biological effects both in vivo 
and in vitro. In recent years increasing evidence has been obtained which 
suggests that modulation of cell proliferation and differentiation are impor-
tant factors. Cell proliferation and differentiation are supposed to be 
processes in which intercellular communication via gap junctions plays an 
essential role. 
Evidence that tumor promoters can inhibit intercellular communication was 
first obtained by Yotti et al., (1979) and Murray and Fitzgerald (1979). Stu-
dies of Yancy et al. (1982) and Kalimi and Sirsat (1984) have shown that 
addition of TPA decreased the number of gap junctions in cultured cells as 
well as in mouse skin. Inhibition of intercellular communication has been 
studied in a variety of cultured cells by means of inhibition of metabolic 
cooperation, electrical coupling and dye transfer methods (Yotti etal., 1979; 
Murray and Fitzgerald, 1979; Loewenstein, 1979; Williams et al., 1981; Telang 
et al., 1982; Trosko et al., 1980; 1983; Enomoto et al., 1984a, b). An increa-
sing data base has been obtained which indicates that many types of promoting 
agents inhibit intercellular communication. Moreover, there is a good correla-
tion between phorbolester mediated inhibition of intercellular communication 
and enhancement of cell transformation in BALB/c3T3 cells (Yamasaki, 1984). 
Chemically transformed cells do not communicate with surrounding non-transfor-
med cells and reported anti tumor promoting agents antagonize the phorbol 
ester mediated inhibition of intercellular communication (Shuin et al-, 1983; 
Yamasaki et al., 1984; Nishino et al., 1984; Boreiko et al., 1987). 
So far only very little attention has been paid to the role of metabolism in 
the formation of compounds with promoting activities in vitro, since most cell 
cultures used in this type of research do not possess significant levels of 
biotransformation enzymes. In this respect the use of primary chick-embryo 
hepatocytes co-cultivated with V79 Chinese hamster cells offers a promising 
model. Several studies have shown that these hepatocytes maintain their bio-
transformation capacity in culture for several days and that they are able to 
metabolize a wide range of indirect acting mutagens and carcinogens (van der 
Hoeven et al., 1984; Bruggeman and van der Hoeven, 1985; Jongen et al., 1985, 
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1986; Topp and van Bladeren, 1986). In the previous chapter I t was demon-
s t r a t e d t h a t a d d i t i o n of TPA or c i g a r e t t e - s m o k e c o n d e n s a t e t o t h i s 
c o - c u l t i v a t i o n system inh ib i t ed the t r a n s f e r of mutagenic in termedia tes from 
the metabolizing c e l l s to the t a r g e t c e l l s (Jongen e t a l . , 1986). This obser -
v a t i o n suggested t h a t metabolic cooperat ion occurred between the two c e l l 
types and tha t t r a n s f e r of in te rmedia tes of benzo(a)pyrene and d ime thy ln i t ro s -
amine metabo l i t e s a l so took p lace through gap j u n c t i o n s . 
The purpose of t h i s chapter was twofold. The f i r s t aim was to i n v e s t i g a t e 
whe the r func t iona l gap junc t ions were r e a l l y formed between the two c e l l 
types . The second aim was to study the p o s s i b i l i t y to develop a t e s t system 
for i n h i b i t i o n of metabolic cooperat ion using t h i s c o - c u l t i v a t i o n system. 
MATERIAL and METHODS 
M a t e r i a l . 
[^ H] labeled hypoxanthine was obtained from Amersham, England. The photogra-
phic emulsion NTB2 was from Kodak, Rochester, U.S.A.. Mitomycin C was obtained 
from Sigma, St Louis, MO, U.S.A.. Petriperm dishes were obtained from Heraeus, 
Hanau, FRG. 
Methods. 
Cel l cu l tu r ing 
In the experiments for the e l e c t r o n microscopy s tud ies the c e l l s were co -cu l -
tured in Hams F10 (Flow) supplemented with 10% newborn calfserum (Gibco). For 
the t r a n s f e r s tud ies of labeled n u c l e o t i d e s , the c e l l s were co-cul tured in 
Dulbecco's MEM (Flow) without hypoxanthine supplemented with 10% newborn ca l f -
serum (Gibco) and 5% of a non -e s sen t i a l amino acids so lu t ion (Flow). To a l l 
media p e n i c i l l i n (50 un i t s /ml ) and streptomycin (50 jjg/ml; Gist-Brocades) were 
added. 
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Electron microscopy studies 
Transmission electron microscopy of sectioned material. 
V79 cells were brought on microscopical cover slips placed in sterile tissue 
culture multi-well dishes. After 4 hr the medium was removed and 1 ml of a 
suspension of primary chick-embryo hepatocytes was added (5x10° hepatocytes 
/ml). Four hours later the medium was replaced again and the test compounds 
were added (TPA: 0.01ug/ml; CSC: 32 yg/ml). At different time intervals after 
start of the exposure three coverslips were washed three times with 0.1 M 
cacodylate buffer (pH 7.4). Fixation was done in 2.5% glutaraldehyde in caco-
dylate buffer (pH 7.4) for 30 min followed by treatment with the same solution 
complemented with either lanthanium nitrate or 0.5-0.8% ruthenium red. All 
further steps in the fixation procedure contained these tracers. After washing 
the cover slips three times with the cacodylate buffer, the cells were fixed 
in 1% osmium tetraoxide for 3 hr. Then the cells were stained with uranyl 
acetate (0.5%) for 1 hr in the dark and dehydrated in an ethanol series. The 
dehydrated material was treated twice with propylene oxide and plastic (a 
mixture of epon: araldite: DDSA= 10:8:24) for 30 min. After impregnation for 
30 min with pure plastic, the cells were embedded in fresh plastic containing 
a small amount of DMP-30. Polymerization took place in a stove at 60° C within 
6 hr. The cover slips were removed from the embedded cell material and this 
was cut into small squares which were glued onto plastic stubs. From this 
material parallel sections (50-100 nm) were cut with a diamond knife and 
stained with uranyl acetate (30 min at 40° C) and lead citrate (40 sec at 20o 
C) in an LKB ultrastainer. 
Quantification of results 
The sections were examined for cell morphology and the presence of gap 
junctions. At every time point 75-100 cells with homologous or heterologous 
neighbouring cells were scored for the presence of gap junctions. The number 
of gap junctions was expressed as the number of contact zones in 100 tangent 
planes between two adjacent cells. 
Transfer of labeled nucleotides 
After isolation the hepatocytes were placed onto 1 cm^ microscope cover slips 
together with HGPRT deficient V79 cells in a ratio of 1:10. After 4hr the 
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medium was replaced to remove dead cell material. The next day [^ H] hypoxan-
thine (10 yCi/ml; specific activity 5 Ci/mmol) was added in a total volume of 
2 ml. After 3-4 hr the medium containing the label was removed and the cells 
were washed four times with Dulbecco's MEM medium containing 0.5 mM hypoxan-
thine. Prior to fixation the cultures were washed three times with ice-cold 
trichloroacetic acid for 10 min. Fixation was carried out with an ethanol/ 
acetic acid mixture (3:1) in three steps; 10 min in a 10% fixative solution in 
Dulbecco's medium; 10 min in a 1:1 mixture of fixative and medium and 10 min 
in a 3:1 mixture of fixative and medium. Finally the cells were washed with 
70% ethanol solution and dried overnight. The cover slips with cells were 
dipped in the NTB2 emulsion at 42° C, dried for 1 hr in the presence of sili-
cagel and kept at 4° C for 4-5 days. The emulsion was developed (D 19, Kodak) 
and fixed. Then the cells were washed with water and stained with a toluidine 
blue solution (0.02% in citrate buffer at pH5) for 10-15 min. The experiments 
were carried out in triplicate and repeated at least once. For each treatment 
the number of grains was determined in at least 25 V7 9 cells. 
RESULTS 
Morphological presence of gap junctions 
Transmission electron microscopy on sectioned material: Structure and number 
of gap junctions between homologous and heterologous cells were investigated. 
V79 Chinese hamster cells and primary chick-embryo hepatocytes differ in size 
and ultrastructural details which makes them easy recognizable (Fig I). 
Gap junctions were formed in vitro between adjacent hepatocytes (Fig IIa) 
between primary chick-embryo hepatocytes and V79 Chinese hamster cells(Fig 
lib) and between neighbouring V79 Chinese hamster cells (Fig lie). Generally, 
the gap junctions between homologous cells were long and the ruthenium red dye 
was excluded (Figs IIa and lie); in contrast gap junctions between hetero-
logous cells were very short and could be recognized merely by the closeness 
of the opposing membranes (Fig lib). 
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Figure I V79 Chinese hamster cells (v) and primary chick-embryo hepato-
cytes in a co-cultivation system. V79 Chinese hamster cells can 
be recognized by light cytoplasma and by endocytotic vesicles and 
invaginations of the plasma membrane. The hepatocytes are charac-
terized by dense cytoplasma and by large lipid bodies(l). 
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Figure II A: Large gap junction (between arrow heads) between two chick 
embryo hepatocytes. Ruthenium red dye has not penetrated into the junction. 
40.000x. B: Contact area between a V79 Chinese hamster cell (V) and a primary 
chick-embryo hepatocyte (H). Small gap junctions ( arrow heads) are present 
but dye is not excluded. 40.000x. C: Large gap junction (between arrow heads) 
between two V79 Chinese hamster cells excluding dye from between the lamellae. 
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There were also numerical differences between the gap junctions of the dif-
ferent cell types: gap junctions formed between primary chick embryo hepato-
cytes were most numerous, followed by the gap junctions formed between V79 
Chinese hamster cells and those formed between the primary chick-embryo hepa-
tocytes and the V79 Chinese hamster cells. The number of gap junctions was 
quantified for the three types at different time points after t=0 both with 
and without replacement of the culture medium (Table I). 
Table I Effect of culture time on the presence of gap junctions in a co-
cultivation system consisting of primary chick-embryo hepatocytes 
and V79 Chinese hamster cells. 
GAP JUNCTIONS / 100 CONTACT ZONES 
time (hr) not replaced replaced (*) 
H-H V79-V79 H-V79 H-H V79-V79 H-V79 
0 
1 
12 
19 
48 
34 
34 
35 
nt 
35 
19 
21 
21 
nt 
21 
14 
13 
13 
nt 
14 
34 
31 
nt 
30 
29 
19 
16 
nt 
16 
16 
14 
12 
nt 
11 
19 
H- primary chick-embryo hepatocytes; V79- Chinese hamster cells; 
nt- not tested; (*)- the culture medium was replaced every 12 hr. 
When the culture medium was not replaced the number of gap junctions did not 
change for at lest 48 hr. However when the medium was replaced every 12 hr a 
small decrease in the number of gap junctions was observed. 
Transfer of labeled nucleotides 
To see whether the gap junctions, formed between the primary chick embryo 
hepatocytes and the V79 Chinese hamster cells were functional in that they 
would allow the passage of molecules, HGPRT deficient mutants of the V7 9 cell 
line were used. These mutants are unable to phosphorylate the hypoxanthine 
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present in the culture medium. When [%] hypoxanthlne is added to a culture of 
these mutants no label will be incorporated. Only when these cells, are co-
cultured with normal cells and phosphorylated hypoxanthine is transferred into 
the mutant cells via gap junctions incorporation will occur ultimately resul-
ting in an increased number of grains/cell. 
First the concentration of [-^ H] hypoxanthine necessary to get heavily labeled 
hepatocytes was studied. In the dose range of 1-10 pCi/ml, using a labeling 
time of 7 hr, the highest dose gave the best labeling. Next the optimal labe-
ling time was determined. The data are presented in Figure III and show that 
after 1 hr a steady state situation was reached for the percentage of heavily 
labeled hepatocytes. 
Figure III The relation between labeling time and the percentage of labeled 
cells in a co-cultivation system consisting of primary chick-
embryo hepatocytes and V79 Chinese hamster cells. 
labeled cells (%) 
100 
3 4 5 
labeling time (h) 
° HGPRT deficient V79 cells 
• hepatocytes 
Labeling is with [^ H] hypoxanthine (10 /iCi/ml; specific activity 5 Ci/mmol) . 
Data are the average value of one experiment carried out in triplicate. 
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It should be emphasized that only those cells were counted which contained so 
much label that the number of grains could not be determined. In addition 
there was always a number of hepatocytes which were labeled less heavily 
(about 10% of the total population). When the transfer of radioactivity from 
hepatocytes to V7 9 mutant cells was studied, the optimal labeling time 
appeared to be at least 2 h (Fig III). Under those conditions the highest 
percentage of labeled V79 mutant cells was 75%. Only those cells were consi-
dered which were in direct contact with a heavily labeled hepatocyte and a 
cell was considered to be labeled when the number of grains was at least three 
times the background value. When [^ H] hypoxanthine was added to a monoculture 
of the V79 mutants, the number of grains never exceeded background values (1-2 
grains/cell). When the same cells were co-cultured with primary chick-embryo 
hepatocytes the number of grains increased to an average value of 13 grains/-
cell (Figure IV, control value). 
Inhibition of metabolic cooperation 
The next objective was to investigate whether known inhibitors of metabolic 
cooperation were capable of inhibiting the transfer of labeled molecules. 
Figure IV presents the effects of TPA on the transfer. 
Figure IV Effect of the phorbolester TPA on the transfer of [ Ü] hypo-
xanthine from primary chick-embryo hepatocytes to HGPRT deficient 
V79 Chinese hamster cells. 
1 2 
log[TPA(ng/ml)] 
Data are average values of two experiments and are given with their S.D.. 
Labeling time with [3H] hypoxanthine was 4 hr with 10 /iCi/ml. Treatment time 
with TPA was 4 hr. 
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Addition of TPA caused a dose related decrease in the number of grains with a 
maximal inhibition at 100 ng/ml. At this dose the number of grains/cell was 
reduced to background values. When the effects of different exposure times 
were studied, inhibition was already maximal after 4 hr (Fig V). 
Figure V Effect of culture time on the inhibitory potential of the 
phorbolester TFA on the transfer of [%] hypoxanthine from 
primary chick-embryo hepatocytes to HGPRT deficient V79 Chinese 
hamster cells. 
grains/cell 
16 24 
tïmelh ] 
Data are the average values of two experiments and are given with their S.D. 
Labeling time with [^ H] hypoxanthine was 4 hr with 10 /iCi/ml. 
However, after longer exposure times an increase in the number of grains was 
observed. To exclude the possibility that recovery of metabolic cooperation 
was due to metabolic breakdown of the TPA, the culture medium was replaced 12 
hr after plating and just before the [^ H] hypoxanthine was added. When DMBA 
and CSC were tested both compounds appeared to inhibit metabolic cooperation 
in the co-cultivation system in a dose related way (Table II). The concen-
trations applied did not cause a reduction in cell surival, measured as pla-
ting efficiency. 
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Table II Inhibitory effects of dimethylbenzanthracene (DMBA) and cigarette 
smoke condensate on the metabolic cooperation between primary 
chick embryo hepatocytes and V79 Chinese hamster cells. 
Exposure Concentration (/ig/ml) P E (%) 
Control 
TPA 
DMBA 
CSC 
0.1 
2.0 
4.0 
8.0 
16.0 
95 
95 
89 
94 
90 
95 
grains/cell 
9.7±1.4 
1.3±0.5 
5.0+1.2 
1.2+1.4 
8.3±1.8 
3.0±1.4 
Data are average values of two experiments carried out in triplicate and are 
given with their SEM. Labeling time with [3H] hypoxanthine is 4 h with 10 
/jCi/ml. Exposure time is 4 h. P E - plating efficiency of V79 cells after a 4 
hr exposure. 
The morphological aspects of exposure to TPA were also studied. In the first 
experiments the effect of TPA (10 ng/ml) on the number of gap junctions was 
quantified at different time intervals (Figure VI). A distinction was made 
between the three possible types of gap junctions occurring. Gap junctions 
formed between the hepatocytes were present in the highest number. After 
addition of TPA a fast initial decrease of 30% was observed after 30 min, 
followed by a slower decrease until no gap junctions were seen after 12 hr. At 
incubation times longer than 12 hr, a slow but continuous increase was obser-
ved. Gap junctions occurring between V79 cells disappeared much faster. After 
exposure to TPA for 20 min they had completely disappeared. This type of gap 
junction also reappeared after longer exposure times. Most importantly, 
heterologous gap junctions, formed between the primary chick-embryo hepato-
cytes and V79 Chinese hamster cells behaved more or less like homologous 
hepatocyte gap junctions. 
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Figure VI Effect of the phorbolester TPA on the presence of gap junctions 
in a co-cultivâtion system consisting of primary chick-embryo 
hepatocytes and V79 Chinese hamster cells. 
gap junctions/100 cells 
TPA (0.01 ug/ml) 
o hep - hep 
o V79 - V79 
x hep - V79 
Reappearance of gap junctions in connection with an increased transfer of 
labeled nucleotides is hypothesized to be related to cell growth and not to 
adaptation of cells. Therefore the V79 cells were pretreated with mitomycin C, 
a cross linking agent, which at the concentration applied (25 yg/ml) prohibits 
cell division but not protein synthesis (Swain, 1977). The results are summa-
rized in Table III. 
After longer TPA exposure (20 hr), the transfer of labeled nucleotides is 
completely inhibited in the mitomycin C pretreated cells whereas the non-pre-
treated cells show a partially restored transfer after the same exposure time. 
The amount of grains/cell in the groups treated with mitomycin C without 
addition of TPA and after 4 hr TPA application does not differ significantly 
from the control groups. This indicates that there is no effect of mitomycin C 
treatment on gap junction formation and intercellular communication or an 
aspecific effect on hypoxanthine metabolism. 
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Table III The effect of Mitomycin C treatment on the restore of intercel-
lular communication between primary chick-embryo hepatocytes and 
V79 Chinese hamster cells during exposure to TFA. 
Treatment 
Exposure time (hr) Mitomycin C (25 /ig/ml) none 
Control 4 
20 
10.7±0.9 
11.2±1.3 
11.7±1.1 
11.1±1.0 
TPA (*) 4 
20 
1.7±0.9 
1.3±0.8 
2.6±0.8 
6.1±1.3 
Experiments were carried out in triplicate. Data are average values of one 
experiment and are given with their SEM. (*) Exposure to TPA was 0.1 /ig/ml. 
Table IV Effect of cigarette-smoke condensate on the presence of gap junc-
tions in a co-cultivation system consisting of primary chick-
embryo hepatocytes and V79 Chinese hamster cells. 
time (hr) 
GAP JUNCTIONS / 100 CONTACT ZONES 
Control 
H-H V79-V79 H-V79 
CSC (32 Mg/ml) 
H-H V79-V79 H-V79 
0 
0.5 
1.0 
12.0 
48.0 
34 
nt 
33 
33 
33 
19 
nt 
21 
22 
21 
14 
nt 
13 
13 
13 
33 
32 
36 
35 
32 
18 
17 
16 
16 
16 
14 
13 
15 
15 
13 
H= primary chick-embryo hepatocytes; nt- not tested. 
The morphological effects of cigarette-smoke condensate, another inhibitor of 
metabolic coperation, were also investigated. The sample used in this study 
originates from the same batch as was used in all other studies. The results 
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are summarized in Table IV and show that no decrease in the number of gap 
junctions was observed after exposure to 32 yg/ml. 
DISCUSSION 
In this chapter data are presented which show that gap junctions are formed 
between primary chick-embry hepatocytes and V79 Chinese hamster cells and that 
these gap junctions allow the passage of labeled nucleotides. 
Increasing evidence has been obtained that inhibition of intercellular commu-
nication between cells is an important determinant of the tumor promoting 
properties of compounds (Trosko et al., 1983; Yamasaki, 1984). Several test 
methods have been developed to measure inhibition of metabolic cooperation by 
means of transfer of poisonous base analogues, electrical coupling and dye 
transfer (Yotti et al., 1979; Murray and Fitzgerald, 1979; Loewenstein, 1979; 
Enomoto et al., 1984a, b). However, sofar only very little attention has been 
paid to the role of drug metabolism in the formation of compounds capable of 
inhibition of intercellular communication. One example in this category is the 
indirect acting carcinogen dimethylbenzanthracene (DMBA). When this compound 
was tested in the co-cultivation system at non-cytotoxic concentrations, in-
hibition of metabolic cooperation was observed (Table II). This is in 
agreement with data published by Tachikawa et al. (1986). They reported that 
exposure to DMBA resulted in a decrease of electrical signal transduction and 
morphologically the number of gap junctions occurring in primary lingual cells 
was drastically reduced.In that respect the test system presented in this 
study has several advantages. Primary chick-embryo hepatocytes are capable of 
metabolizing a wide range of xenobiotics (van der Hoeven et al., 1984; 
Bruggeman and van der Hoeven,1984, 1985; Jongen et al., 1985, 1986). In vitro 
they maintain their biotransformation capacity for at least 72 hr after pla-
ting. Treatment with known enzyme inducers leads to induction rates compa-
rable with in vivo situations (Jongen et al., 1986; Topp and van Bladeren, 
1986) which allow also the study of modulating factors. Addition of TPA caused 
a dose-related decrease in the number of grains in the V79 mutant cells. Mor-
phologically this was accompanied by disappearance of all three types gap 
junctions. However, there was a remarkable difference in response time between 
the two cell types. Gap junctions formed between V7 9 cells responded much 
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faster than those formed between primary chick-embryo hepatocytes. This is in 
agreement with the findings of Yancy et al.(1982). The heterologous gap 
junctions behaved like hepatocyte junctions. When cigarette-smoke condensate 
was tested no reduction in the number of gap junctions was observed. The con-
centration applied is toxic, at least for V79 Chinese hamster cells (Jongen 
et al., 1985). Beside this, the dose used in these experiments inhibits meta-
bolic cooperation between V79 cells (Jongen et al., 1985; Hartman and Rosen, 
1984) and the complex mixture also inhibits transfer of labeled nucleotides in 
the co-cultivation system. This raises the question whether the absence of 
morphological effects is due to a different mechanism of CSC or that the hepa-
tocytes are capable of detoxifying the complex mixture with respect to this, 
direct acting, property. An argument in favor of the first hypothesis is pro-
vided by the observation that in this co-cultivation system CSC, like TPA, is 
capable of inhibition of the transport of reactive intermediates from the 
metabolizing cells to the target cells. 
The reappearance of the gap junctions after longer exposure times to TPA 
parallels the increased transfer of labeled nucleotides. Probably this is not 
due to metabolic breakdown of the TPA since the compound was replaced in the 
transfer experiments. This biphasic effect of exposure to TPA has been obser-
ved also by several other investigators (Dorman and Boreiko, 1983; Enomoto and 
Yamasaki., 1985; Kalimi and Sirsat, 1984). Dorman et al. (1983) studied the 
role of intercellular communication in the promotion of C3H 10T1/2 cell trans-
formation. No correlation was found between the doses of TPA required for 
promotion and since inhibition of intercellular communication was transient 
they hypothesized that inhibition of intercellular communication is not a 
sufficient event for tumor promotion. 
The data obtained in this study with mitomycin C suggest that the duration of 
inhibition of intercellular communication is largely dependent on the growing 
state of the cells. When the cells do not divide inhibition is continuous. 
This observation is consistent with the findings of Yamasaki et al., (1984) 
who reported that inhibition of intercellular communication between cells in 
culture was transient when the cultured cells were sub-confluent but that 
inhibition was continuous when confluent cultures were used. 
In the previous chapter it was shown that addition of TPA and cigarette-smoke 
condensate to this co-cultivation system inhibited benzo(a)pyrene induced 
mutagenicity in the V79 cells. In that paper the conclusion was drawn that 
these inhibitory effects were due to inhibition of transport of reactive 
intermediates. Those data, combined with the results presented in this chapter 
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justify the conclusion that a considerable part of the reactive intermediates 
is transported from the metabolizing cells to the target cells through gap 
junctions. 
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THE USE OF THE CO-CULTIVATION SYSTEM TO STUDY 
MECHANISMS OF CANCER MODULATING COMPOUNDS 
A. MODULATING EFFECTS OF NATURALLY OCCURRING INDOLES ON SCE INDUCTION 
BY MODEL COMPOUNDS 
ABSTRACT 
The enzyme inducing c a p a b i l i t i e s of the n a t u r a l l y occurr ing indoles i n d o l e - 3 -
carb inol (I3C) and i n d o l e - 3 - a c e t o n i t r i l (I3A) on cytochrome P450 as soc ia t ed 
enzymes and conjugating enzymes were s tudied in cul tured primary chick-embryo 
hepa tocytes . In add i t ion the modulating e f f ec t s of pretreatment with these 
indoles on the induct ion of SCEs by mutagens from d i f f e r e n t chemical c l a s se s 
were i n v e s t i g a t e d . F i n a l l y , the e f f ec t of pretreatment with I3C on B(a)P meta-
bolism was s tudied in more d e t a i l . At 25 pg/ml I3C induced e thoxyresoruf in-0 
deethylase (EROD) a cytochrome P448 assoc ia ted enzyme, a c t i v i t y 3.9 fold and 
ethoxycoumarin-O-deethylase (ETCO), a cytochrome P448/450 assoc ia ted enzyme, 
a c t i v i t y 2-fold; UDP-glucuronyltransferase a c t i v i t y (UDPGT) with 3-OH B(a)P as 
s u b s t r a t e was increased 2 - fo ld . No induct ion of g l u t a t h i o n e - S - t r a n s f e r a s e was 
found. I3A showed optimal induct ion a t 35 pg/ml . ; EROD a c t i v i t y was increased 
1.6 fold and ETCO a c t i v i t y 2 - fo ld . UDPGT was increased 2-fold whereas again no 
increase was observed for g l u t a t h i o n e - S - t r a n s f e r a s e . The i n d u c t i o n r a t i o s 
between UDPGT a c t i v i t y and cytochrome P450 content was s tudied a f t e r treatment 
with var ious induce r s . Induct ion with both I3C and I3A r e su l t ed in r a t i o s 
comparable to the con t ro l s i t u a t i o n whereas induct ion with 3-methylcholan-
threne r e su l t ed in a considerable decrease in t h i s r a t i o (UDPGT a c t i v i t y / c y t o -
chrome P450 c o n t e n t ) . Kine t ic s tud ies showed tha t both indoles a re able to 
i n h i b i t EROD a c t i v i t y in chick-embryo hepatocyte microsomes p re t r ea t ed with B-
naphtoflavone with I3C having a higher a f f i n i t y than I3A. Pre t rea tment with 
I3C r e s u l t e d in a 20-40% decrease in SCE induct ion by benzo(a)pyrene [B(a)P] 
and dime thy ln i t rosamine (NDMA). No decrease in SCE induct ion was observed for 
2-aminoanthracene (2AA) and dibromoethane (DBE) and the d i r e c t ac t ing a l k y l a -
t ing agent ethylmethanesulfonate (EMS). Pre t rea tment wi th I3A again r e su l t ed 
in a 20-40% decrease in SCE induct ion for B(a)P whereas no decrease was obse r -
ved for DMNA, 2AA and EMS. When a microsomal f r a c t i o n prepared from I3C-pre-
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treated hepatocytes was used, no decrease in B(a)P-induced SCEs was found; in 
contrast, use of an S-9 fraction prepared from the same cells resulted in a 
45% decrease. In addition the profile of metabolite formation from B(a)P was 
studied. Pretreatment with I3C resulted in a considerable increase in total 
conversion. When the relative amounts of the individual metabolites were com-
pared with those obtained after 3-MC pretreatment no significant differences 
could be observed. The data obtained in this study indicate that the protec-
tive effects of pretreatment with indoles are not directly correlated with 
induction of cytochrome P450 associated enzymes. Although both I3A and I3C are 
good candidates to act as competitive inhibitors for B(a)P metabolism this 
seems to be of minor importance in this study. Instead the protective effects 
seem to result from a changed balance of the enzyme systems involved in the 
indole biotransformation process and point to an essential role of the conju-
gating enzyme systems. 
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INTRODUCTION 
Epidemiological data indicate that consumption of cruciferous vegetables i s 
associated with a decreased incidence of cancer in human populations (Graham, 
1983; Hirayama, 1986). The anticarcinogenic properties of cruciferous vege-
tables and isolated compounds have been studied in several investigations. 
When animals were f i r s t fed on diets high in cruciferous vegetables and then 
exposed to various indirect acting carcinogens, tumour yields were lower and 
survival rates were higher than similarly treated animals on semi-purified 
diets (Boyd et a l . , 1982; Stoewsand et a l . , 1978; Wattenberg, 1983). Subse-
quent ly, i so la t ion and identif ication of the principal compounds involved 
showed that they were indoles (Loub et a l . , 1975). When the identified com-
pounds were tested, indole-3-carbinol (I3C), 3,3'-diindolylmethane and indole-
3-acetonitr i le (I3A) a l l appeared to inhibit the induction of forestomach 
neoplasia by benzo(a)pyrene [B(a)P]. I3C and 3,3'-diindolylmethane also inhi-
bited 7,12 dimethylbenzanthracene-induced mammary tumours although I3A did not 
(Wattenberg and Loub, 1978). The mode of action of th is type of anticarcino-
genic compounds may be a quali tat ive and quantitative change in the meta-
bolism of the carcinogens. In contrast to a l l these findings, Pence et a l . 
(1986) reported recently that indole-3-carbinol enhanced dimethylhydrazine 
induced tumor formation. Apparently the type of modulation is largely depen-
dent on the choice of the model compound. A number of cruciferous plants, 
including Brussels sprouts, cabbage, cauliflower and broccoli have been found 
to induce aryl hydrocarbon hydroxylase (AHH) act ivi ty (Wattenberg et a l . , 
1976) and/or the activi ty of cytosolic glutathione-S-transferase (Sparnins et 
a l . , 1982). Moreover, I3C and to a lesser extent, I3A appeared to be s igni-
ficant inducers of hepatic and in tes t inal monooxygenase (Loub et a l . , 1975) 
and glutathione-S-transferase (Sparnins et a l . , 1982) ac t i v i t i e s . Sofar in 
v i t ro data on the protective effects of pretreatment with indoles against the 
DNA damaging capacity of carcinogens have not been reported. Probably this i s 
due mainly to the fact that in most in vi t ro systems i t is not possible to 
induce biotransformation enzymes. As has been argued in Chapter I I the use of 
in vi tro cultures of primary chick-embryo hepatocytes offers a potential use-
ful model to study modulating effects of indoles. These hepatocytes maintain 
their biotransformation capacity in vi tro for up to 72 h without loss of 
ac t iv i ty . Moreover induction with known enzyme inducers leads to enzyme induc-
tion comparable with that occurring in in vivo situations (Althaus et a l . , 
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1979; Giger and Meyer, 1981; Topp and van Bladeren, 1986). In t h i s study the 
e f f ec t s of t r e a t i n g the primary chick-embryo hepatocytes with I3C and I3A on 
var ious enzyme systems involved in the b io t ransformat ion process were inves -
t i g a t e d . In add i t i on the p r o t e c t i v e e f f ec t s of these compounds aga ins t s eve ra l 
i n d i r e c t - a c t i n g carcinogens were s tudied in the c o - c u l t i v a t i o n system cons i s -
t i ng of primary chick-embryo hepatocytes and V79 Chinese hamster c e l l s . 
MATERIALS and METHODS 
Mater ia ls 
Ethoxycoumarin, I3C, I3A, B(a)P and t r y p s i n were a l l obtained from Sigma 
Chemical Co. (St Louis , MO, USA).Dimethylnitrosamine (NDMA) and d imethylsu l -
foxide (DMSO), which was used as so lvent , were from E. Merck AG (Darmstadt, 
FRG). NADP, NADPH and glucose-6-phosphate were o b t a i n e d from B o e h r i n g e r 
Mannheim GmbH (Mannheim, FRG). Ethoxyresoruf in was obtained from P ie rce 
Eurochemie BV, Oud-Beijerland. 
Methods 
Hepatocyte isolation. The isolation of the primary chick-embryo hepatocytes 
was performed as described in Chapter II. 
Mutagenicity assay. From the suspension of hepatocytes, 5 ml was plated in 
Petri dishes (6-cm in diameter) and incubated for 24 h in a CO2 incubator. The 
medium was replaced to remove dead cell materia,l and I3A or I3C was added. At 
different time points after start of this treatment, the medium was removed 
and the cells were exposed for a specific time. After removal of the test 
compound, the cells were washed twice with a physiological salt solution, 
dissociated with trypsin (0.2%) suspended in Hams F10 medium supplemented with 
10% newborn calf serum, penicillin (50 units/ml) and streptomycin (50 yg/ml) 
plated onto microscope slides (10^ cells/slide) and incubated for 2 h to allow 
the cells to attach. The sister chromatid exchange (SCE) assay was performed 
according to Perry and Wolff (1974) with slight modifications described else-
where (Jongen et al, 1985). The assay was initiated according to Jongen et al. 
(1981). In all experiments, control cells were treated with the solvent (DMSO) 
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in an amount equal to that used for the treated cells. The DMSO concentrations 
never exceeded 0.2%. All experiments were repeated at least once. The percen-
tage decrease was calculated after subtraction of the control values from the 
values obtained with the exposed cells. 
Preparation of liver homogenate and microsomes. The hepatocyte suspension 
(6xl05 hepatocytes/ml) was plated in 6-cm diameter Petri dishes (5 ml/dish) 
and incubated at 37° C in a humidified atmosphere containing 5% C02» After 24 
h the medium was replaced and appropriate amounts of test compounds were ad-
ded. At different intervals after addition of the test compounds, the hepa-
tocytes were washed twice with saline phosphate buffer (pH7.4, 0.1 M ) , scraped 
off the dishes and suspended in a total volume of 0.4 ml/dish. After homogeni-
zation of the suspension in a glass Potter-Elvehjem homogenizer, the homo-
genate was centrifuged for 15 min at 9,000 g. The supernatant was collected 
and contained approximately 0.5 mg protein/ml. The S-9 was kept in liquid 
nitrogen at -196° C and S-9 mix was prepared as described in Chapter II. The 
microsomal fraction was prepared by centrifuging the S-9 at 105,000 g for 90 
min. The supernatant was discarded and the pellet was resuspended in the ori-
ginal volume with O.lM-phosphate buffer (pH 7.4) containing 0.1 mM EDTA. The 
microsomal fraction was kept in liquid nitrogen. Previous experiments showed 
that in a period of at least 1 month, no change in enzyme activity was obser-
ved. The mix contained 20% microsomal fraction and was prepared as the S-9 mix 
except that NADPH was added instead of NADP. 
In ovo treatment. 15 day-old chick embryos were injected with a sterile needle 
through the membrane of the air chamber. Injection was done with 50 yl of a 
DMSO solution containing the various enzyme inducers. After 22 h the injection 
was repeated and 22 h later the embryos were killed and the liver material was 
isolated sterile. Preparation of the respective enzyme fractions was performed 
as described in Chapter II. 
B(a)P metabolite formation. The reaction mixture (total volume 6.0 ml in phos-
phate buffer; 0.1M;pH 7.4) consisted of the microsomal fraction (3 nmol cyto-
chrome P450), 18 mol MgCl2, 3.36 mol NADPH and 300 nmol B(a)P mixed with 12 
ViCi [3H] B(a)P (specific activity 7.63 Ci/mmol). 
After preincubation of the microsomal fraction and co-factors for 2 min at 37° 
C the reaction was started by addition of the B(a)P solution (200 pi of a 
acetone solution). Incubation was done for varying times (5, 10 and 15 min). 
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At these time-points 2.0 ml of the mixture was mixed with 2.0 ml of acetone to 
terminate the reaction. To each tube 4.0 ml of ethylacetate was added and the 
mixtures were extracted for 3 min on a vortex. The organic layer was trans-
ferred into a tube containing 1 g of anhydrous Na2S04 and kept overnight at 
-20° C. The aqueous layer was collected and counted in a liquid scintillation 
counter. The organic layer was evaporated under nitrogen and the residue dis-
solved in 100 yl of methanol. This sample was mixed with 20 yl of a standard 
mixture and injected onto a HPLC column (Lichrosorb 5-RP18; 150x4.6 mm). The 
metabolites were separated using a water/ methanol gradient program as des-
cribed by Thakker et al. (1978). Detection was performed with UV at 254 nm. 
Fractions of 1.2 ml were collected and radioactivity was determined in each 
fraction with liquid scintillation counting. 
Enzyme assays 
Protein. The protein content of the subcellular fractions was determined with 
the biorad method developed by Bradford (1976). 
Cytochrome P450. Cytochrome P450 content was determined by its CO-binding 
spectrum according to the method of Omura and Sato (1964) on a single beam 
spectrofotometer. Absorption maxima of the Soret bands were determined by 
applying first derivative spectrofotometry. 
Ethoxyresorufin-O-deethyläse. The method used to measure ER0D activity was 
essentially that described by Burke and Mayer (1974). The monolayers of pri-
mary chick-embryo hepatocytes were washed three times with an ice-cold buffer 
solution (Tris-HCl, 0.1M. pH 7.8) and the cells were scraped off the dishes 
and suspended in 0.5 ml buffer. 
The suspension was homogenized, as described before, and centrifuged for 30 
sec at 14,000 g in a Beekman microfuge. The supernatant was collected and 0.1 
ml was transferred into a 1 cm cuvette. After addition of 1.0 ml ethoxyreso-
ruf in solution (10 M) in buffer, the mixture was pre incubated for 1 min at 
37° C. 
After measurement of the endogenous activity, the reaction was started by 
addition of 1-5 1 of NADPH solution (lOmM). The reaction was monitored 
fluorimetrically using excitation and emission wavelengths of 510 and 586 nm, 
respectively, and the enzyme activity was calculated from the slope of the 
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l i n e a r par t of the a c t i v i t y curve . 
E thoxycoumar in -Q-dee thy la t ion . The method for measuring ETCO a c t i v i t y was 
i d e n t i c a l to the procedure used for ERDD a c t i v i t y but used 7-ethoxycoumarin 
(1 mM in Tris-HCl) as the s u b s t r a t e . The reac t ion was monitored f l u o r i m e t r i -
c a l l y using wavelengths of 360 nm ( e x c i t a t i o n ) and 460 nm (emiss ion) . 
Glut a t h i o n e - S - t r a n s f e r a s e . GSH-transferase a c t i v i t y was determined spec t ro -
fo tomet r i ca l ly according to Baars e t a l . (1979) using 1-chloro 2 , 4 - d i n i t r o b e n -
zene (CDNB) as s u b s t r a t e . The assay cons is ted of 1.25 ml 0.13 M phosphate 
buffer , 3 mM EDTA, pH 8.0; 0.10 ml 100,000 g supernatant containing 15 g 
p ro te in /ml ; Glutathione , 0.1 ml in d i s t i l l e d water ( f i n a l concen t ra t ion 1.0 
mM); CDNB in 0.05 ml e thanol ( f i n a l concent ra t ion 1.0 mM). The r eac t i on mix-
tu r e was pre incubated a t 37° C for 2 min before the r eac t i on was s t a r t e d by 
add i t ion of the s u b s t r a t e . Incubat ion took place in a shaking water bath for 3 
min a t 37° C. Under these condi t ions product formation i s l i n e a r with time and 
with p ro t e in concen t ra t ion . The r eac t i on i s monitored spec t ro fo tome t r i ca l ly a t 
340 nm. Enzyme a c t i v i t y was ca lcu la ted from the l i n e a r pa r t of the a c t i v i t y 
curve. 
UDP-glucuronyl t r a n s f e r a s e . Enzyme a c t i v i t y was measured using the method of 
Singh and Wiebel (1979) with minor modif icat ions using 3-0H-B(a)P as sub-
s t r a t e . I so l a t ed primary chick-embryo hepatocytes were cul tured for 24 h and 
subsequen t ly t r e a t e d with the var ious enzyme inducers for 22 h. Then the 
medium was replaced by medium (5 .1 ml) conta in ing 0.4% 3-0H-B(a)P (3 .1 M) and 
2% UDPGA (37.2mM). At var ious time po in t s a f t e r the s t a r t of the incubat ion 
samples of 0.4 ml of medium were taken, 0.6 ml of water was added followed by 
e x t r a c t i o n wi th 6 ml of a chloroform/methanol mixture ( 2 : 1 ) . After c e n t r i f u -
gat ion for 10 min a t 1500 g, 1.0 ml of the aqueous phase was c o l l e c t e d and 
kept a t -20° C overn igh t . After add i t i on of 0.08 ml NaOH (5.0M) to 0.8 ml of 
the co l l ec t ed aqueous phase the formation of the 3-0H-B(a)P glucuronide was 
determined f l u o r i m e t r i c a l l y in a 1 cm cuve t te using wavelengths of 378 nm 
( e x c i t a t i o n ) and 425 nm (emiss ion) . At the end of the experiment in each dish 
the p r o t e i n content and the cytochrome P450 content was determined. 
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RESULTS 
Enzyme activities 
The induction of P450 associated enzymes by treatment of the isolated primary 
chick-embryo hepatocytes with the two indole compounds was studied at dif-
ferent time intervals and with different concentrations. The results are sum-
marized in Figure I and show that each compound induced both EROD and ETCO 
activity. 
Figure I. Activity of ethoxycoumarin-O-deethylase (a, c) and of ethoxy 
resorufin O-deethylase (b, d) in control (0) or treated (0) primary chick-
embryo hepatocytes, the latter being exposed to either 25 /ig indole-3 car-
binol/ml (a, b) or 35 /ig indole-3-acetonitril/ml (c, d) for 0-50 hr. Data 
points are means from duplicate experiments. 
activity (pmol.mg protein" minute I 
1000 
EROD 
3C (25u.g/ml) 
25 50 
treatment time ( h ) 
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When various concentrations of the two compounds in the range 5-50 yg/ml were 
tested, optimal induction was achieved at 25 yg/ml for I3C and at 35 yg/ml for 
I3A (data not shown). 
However the induction kinetics appear to be different for the two compounds. 
I3C was the better inducer of EROD, with a 3.9 fold increase in enzyme acti-
vity after treatment for 20 h at a concentration of 25 yg/ml. I3A gave a much 
smaller increase (1.6 fold) in enzyme activity, the maximum being reached 
after treatment for only 6-8 h with 35 yg/ml, the concentration giving the 
greatest increase. The two compounds showed a greater similarity in their 
effects on ETCO activity; in both the level of increase and the time to attain 
optimal induction, there were no major differences, although the concentra-
tions of I3A needed to yield these effects were higher than those of I3C 
A comparative study of in vitro and in ovo induction, which will be published 
separately (van Bladeren et al., in preparation) showed that no qualitative 
differences in B(a)P metabolism and metabolite patterns were observable after 
pretreatment with different enzyme inducers like 3-methylcholanthrene, Aroclor 
1254 and B-naphtoflavone. Therefore enzyme fractions prepared from in ovo 
pretreated material were also used. 
Inhibition experiments for both I3A and I3C of EROD activity in microsomes 
prepared from chick-embryos treated in ovo with B-naphtoflavone showed that 
both compounds were able to inhibit EROD activity. Determination of the af-
finity constants showed that both compounds can be classified as competitive 
inhibitors for EROD activity (Figure II). The better inducing capacity of I3C 
in the chick-embryo hepatocytes is reflected in a higher affinity constant for 
EROD activity. 
In addition to the effects of pretreatment on P450 associated enzymes the 
effects on conjugating enzymes were also studied. The data for GSH-S-trans-
ferase are summarized in Table I and show that although enzyme activity is 
measurable no increase in activity is found upon treatment with both indoles. 
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Figure II. Determination of the affinity constants of indole-3-carbinol 
(I3C) and indole-3-acetonitril (I3A) for EROD activity in hepatic 
microsomes prepared from chick-embryos pretreated with B naphto-
flavone in ovo. 
Km/VmQX(min.mg.103) 
10 
- •-• Ki= 2.7 M M 
(I)HM 
15-day old chick-embryos are injected twice with a 24 hr interval with B-naph-
toflavone (0.75 mg/egg). 
Table I Glutathione-S-transferase activity in cultured primary chick 
embryo hepatocytes after treatment with naturally occurring indoles. 
Treatment Enzyme Activity (*) 
Control 1.28±0.17 
I3C (25 pg/ml) 0.87+0.11 
I3A (35 Mg/ml) 0.98±0.05 
Phenobarb i tal 1.09±0.12 
(*) Enzyme activity is expressed as mmol GSH-S-transferase/min/mg protein and 
is calculated from the slopes of the regression lines. 
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Phénobarbital which is a known inducer of GSH-S-transferase activity in the 
rat was used as a positive control. However also for this compound no induc-
tion was observed. Apparently this enzyme system cannot be induced under the 
experimental conditions applied. When the effects of treatment on UDP-glucu-
ronyltransferase using 3-0H-B(a)P as substrate were studied all compounds 
tested caused an increase in enzyme activity. The data are summarized in Fi-
gure III and show that treatment with 3-methylcholanthrene gives a small but 
consistent increase in ÜDPGT activity. The effects upon treatment with the 
indoles were considerable. Both I3A and I3C gave a two-fold increase in enzyme 
activity. 
Figure III. UDPglucuronyl transferase activity in cultured primary chick--
embryo hepatocytes after pretreatment with indole-3-carbinol, 
indole-3 acetonitril and 3-methylcholanthrene. 
nmol 3-OH-B. P/ml/mg protein 
Pretreatment with all compounds was 22 hr (I3C: 25 /ig/ml; I3A: 35 /xg/ml; 
3-MC:6 /ig/ml). Activity is expressed as pmol 3-0H-B(a)P/ml/mg protein. 
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In these experiments cytochrome P450 was determined simultaneously and the 
inducing capacity of these compounds on cytochrome P450 content was compared 
with their ability to induce UDPGT activity (Table II). 
Table II Relation between UDPGtransferase (ÜDPGT) activity and cytochrome 
P450 content in cultured primary chick-embryo hepatocytes after 
treatment with various enzyme inducers. 
Ratio UDPGT act./cytochrome P450 (*) 
time (min) treatment 
control 3-MC I3C I3A 
0 0 0 0 0 
20 2.6 1.3 3.5 3.8 
60 9.0 4.3 
80 14.9 10.9 
150 27.9 9.1 
170 27.8 25.4 
240 46.1 15.8 
260 45.2 37.9 
430 50.8 19.4 52.4 44.1 
(*) Ratio is expressed as pmol 3-0H-B(a)P/ml/nmol cytochrome P450. 
After 3-MC pretreatment the ratio between UDPGT activity and cytochrome P-450 
content was three times lower than after pretreatment with both indoles or 
without pretreatment. This indicates that pretreatment with indoles has a 
better protective capacity compared with 3-MC pretreatment. 
Mutagenicity studies 
Because these enzyme studies showed that different types of cytochrome P450 
may be involved in the modulating effects of I3C and I3A, compounds from dif-
ferent chemical classes were used to study the effects of enzyme modulation on 
mutagenicity. 
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Table III Modulating effect of indole-3-carbinol (I3C) pretreatment on SCE 
induction by model compounds in a co-cultivation system consis-
ting of primary chick-embryo hepatocytes and V79 cells. 
SCEs/CHROMOSOME 
Compound 
B(a)P 
(^ ig/ml) 
NDMA 
(Mg/ml) 
2-AA 
(/ig/ml) 
DBE 
(mM) 
EMS 
(Aig/ml) 
Exposure 
Time 
24 hr 
4 hr 
4 hr 
4 hr 
24 hr 
Dose 
0.0 
2.5 
5.0 
7.5 
0.0 
500.0 
1000.0 
1500.0 
2000.0 
0.0 
10.0 
25.0 
50.0 
0.0 
1.05 
5.26 
0.0 
100.0 
Without 
I3C 
0.27±0.02 
0.80±0.10 
0.96±0.03 
1.46±0.08 
0.20+0.01 
0.37+0.04 
0.59+0.06 
0.91±0.04 
1.21±0.06 
0.21+0.04 
0.68±0.07 
0.75+0.02 
0.81±0.10 
0.29±0.03 
0.79±0.11 
1.11±0.05 
0.27±0.02 
1.04+0.04 
With 
I3C 
0.27+0.02 
0.70±0.02 
0.77±0.02 
1.07±0.06 
0.21+0.01 
0.28±0.03 
0.41±0.05 
0.48±0.07 
0.65±0.05 
0.31-0.03 
0.83±0.02 
0.87±0.10 
0.87±0.02 
0.28±0.03 
0.83±0.06 
1.45±0.06 
0.27±0.02 
1.02±0.03 
Change 
(%) 
-
-19* 
-28* 
-33* 
-
-25* 
-30* 
-46* 
-46* 
-
-
-
-
-
-
+40* 
-
-
B(a)P=Benzo(a)pyrene; NDMA=Nitrosodimethylamine; 2AA-2 Aminoanthracene ; DBE= 
Dibromoethane; EMS=Ethylmethanesulfonate. Control cells were treated with 
dimethylsulfoxide. Values given are means ± SEM for one representative expe-
riment carried out in triplicate. Asterix indicates a significant change 
(P<0.05, by Wilcoxon's test) after I3C treatment. I3C pretreatment was with 
25/ig/ml, for 30 hr for the B(a)P assays and for 24 hr for all other assays. 
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Table III summarizes the effects of pretreating the primary chick-embryo 
hepatocytes with I3C on the mutagenicity of different model compounds in the 
SCE assay in V79 cells. Addition of different concentrations of B(a)P caused a 
dose-related decrease in the number of SCEs/chromosome. Pretreatment with I3C 
resulted in a significant decrease at all the dose levels tested. The decrease 
was proportional to the B(a)P dose applied, the lowest dose giving the 
smallest decrease. When NDMA was tested the mutagenicity generated by this 
compound also appeared to be inhibited in a dose-related way by I3C pretreat-
ment. The decrease was comparable to the effects observed with B(a)P. In 
contrast, pretreatment with I3C did not result in any decrease in mutagenicity 
for 2-aminoanthracene (2AA). When dibromoethane was tested pretreated co-cul-
tures even exhibited a higher mutagenicity compared with control cultures. As 
was to be expected, exposure to ethyl methanesulfonate, a directacting com-
pound, generated the same number of SCEs/chromosome with or without pretreat-
ment. The effects of pretreatment with I3A were also studied (Table IV). 
Although I3A gave a much smaller increase in EROD activity than I3C, the two 
compounds gave a similar decrease in the number of SCEs/chromosome generated 
by exposure to B(a)P. In contrast pretreatment with I3A did not result in any 
decrease in NDMA generated mutagenicity. Although at the concentrations used 
both compounds induced ETCO activity to a similar degree, there appears to be 
no correlation between this effect and inhibition of NDMA mutagenicity in the 
SCE assay. When different doses of 2AA were examined also pretreatment with 
I3A did not result in any decrease in mutagenicity. Moreover, in these experi-
ments pretreatment with I3A did not have any effect on the mutagenic activity 
of ethyl methanesulfonate. 
From previous studies it was assumed that longer exposure times gave greater 
mutagenic effects in this co-cultivation system, facilitating the study of 
minor changes in mutagenic effects (Bruggeman and van der Hoeven, 1985; Jongen 
et al., 1985; van der Hoeven et al., 1984). However a theoretical study of 
modulating factors of the biotransformation process raises the possibility 
that when longer exposure times are applied, the model compounds used for 
mutagenicity studies modulate their own biotransformation process and mask 
effects caused by the pretreatment. Therefore different periods of exposure 
to B(a)P were also studied (Table V). 
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Table IV Modulating effect of indole-3-acetonitrll (I3A) pretreatment on 
SCE induction by model compounds in a co-cultivâtion system 
consisting of primary chick-embryo hepatocytes and V79 cells. 
SCEs/CHROMOSOME 
Compound 
B(a)P 
(/ig/ml) 
NDMA 
(mg/ml) 
2AA 
(pg/ml) 
EMS 
(Mg/ml) 
Exposure 
Time 
24 hr 
4 hr 
4 hr 
24 hr 
Dose 
0.0 
3.5 
7 5 
0.0 
1.0 
1.5 
2.0 
0.0 
10.0 
25.0 
0.0 
100.0 
Without 
I3A 
0.34±0.02 
0.84±0.07 
1.60±0.09 
0.25±0.01 
1.03±0.07 
1.20±0.06 
1.33±0.06 
0.26±0.03 
0.61±0.03 
0.79±0.05 
0.34±0.02 
1.07±0.03 
With 
I3A 
0.34±0.02 
0.73±0.05 
1.23±0.02 
0.24±0.01 
1.15±0.06 
1.26±0.13 
1.36±0.02 
0.22+0.04 
0.60±0.07 
0.81±0.08 
0.34±0.02 
1.02±0.03 
Change 
(%) 
-
-22* 
-29* 
-
+16* 
-
-
-
-
-
-
-
B(a)P-Benzo(a)pyrene; NDMA-Nitrosodimethylamine; 2AA-2 Aminoanthracene EMS=-
e thy lme thane sulfonate. I3A pretreatment was with 35 /ig/ml for 8 hr for the 
B(a)P assay and for 24 hr in all other assays. Control cells were treated with 
dimethylsulfoxide. Values are means of one representative experiment carried 
out in triplicate and asterix indicates a significant change (P<0.05, by 
Wilcoxon's test) after pretreatment. 
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Table V Protective effect of indole-3-carbinol (I3C) pretreatment in a 
co-cultivation system, consisting of primary chick-embryo hepa-
tocytes and V79 cells exposed to benzo(a)pyrene for different 
periods. 
SCEs/CHROMOSOME 
Dose Exposure Without 
Treatment (pg/ml) time (hr) I3C 
With 
I3C 
Decrease 
(%) 
control 0.0 1.0 0.32+0.03 0.33+0.05 
B(a)P 7.5 1.0 
2.0 
4 .0 
0.83±0.06 
0.94±0.03 
1.24±0.12 
0.74±0.06 
0.86±0.07 
0.83±0.09 
20* 
13* 
45* 
I3C pretreatment was with 25 ^g/ml for 20 hr. Control cells were treated with 
dimethylsulfoxide. Values are means + S.D. for two combined experiments each 
carried out in duplicate and an asterix indicates a significant decrease 
(P<0.05, by Wilcoxon's test) after I3C pretreatment. 
Increasing exposure times gave higher mutagenicity, but when the hepatocytes 
were pretreated with I3C, increasing the exposure time did not increase the 
mutagenic effect, indicating that the protective effects of pretreatment were 
greater with longer exposure times, a 45% decrease in mutagenicity being 
attained with a 4 h exposure. 
Because the antimutagenic effects of pretreatment did not correlate with the 
induction patterns of cytochrome P450 associated enzymes, mutagenicity at the 
optimal pretreatment time for ER0D induction was compared with that after a 
pretreatment time at which only approximately one third of the maximal in-
crease in EROD activity was observed. The data summarized in Table VI, show 
that even after a non-optimal pretreatment time of only 5 h, a considerable 
decrease in mutagenicity was still observed, indicating that factors other 
than P450 associated enzymes play a significant role. 
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Table VI Inhibitory potential on SCE induction by B(a)P of indole-3-carbi-
nol pretreatments of different duration in a co-cultivation 
system consisting of primary chick-embryo hepatocytes and V79 
cells. 
Treatment 
Dose 
(/jg/ml) 
Duration of 
I3C 
pretreatment 
(hr) 
SCEs/CHROMOSOME 
Without With 
I3C I3C 
Decrease 
(%) 
Control 0.0 0.32±0.04 0.33±0.03 
B(a)P 7.5 1.52±0.07 1.32±0.07 18** 
Control 0.0 20 0.38±0.03 0.36±0.02 
B(a)P 7.5 20 1.60+0.19 1.23±0.10 30** 
Exposure to B(a)P was for 24 hr. Pretreatment with I3C was with 25 /jg/ml. 
Values are means ± SD for five determinations in one representative experiment 
and asteriks indicate a significant decrease (P<0.01, by Wilcoxon's test) 
after I3C pretreatment. 
Therefore experiments were also performed with a pre-incubation assay, in 
which different enzyme fractions, prepared from non-pretreated hepatocytes 
were compared with enzyme fractions prepared from hepatocytes that were pre-
treated with I3C for 20 h. (Table VII). 
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Table VII Comparison of the induction of SCEs by benzo(a)pyrene [B(a)P] in 
a pre-incubation assay with V79 cells, using different enzyme 
fractions prepared from primary chick-embryo liepatocytes pre-
treated with 25 /ig/ml indole-3-carbinol (I3C) for 20 hr. 
SCEs/CHROMOSOME 
Treatment 
Dose Enzyme Without 
(/ig/ml) fraction I3C 
With 
I3C 
Decrease 
(2) 
Control 0.0 S-9 0.34+0.03 0.34±0.03 
B(a)P 7.5 S-9 0.72+0.02 0.55+0.05 45** 
Control 0.0 Microsomes 0.38+0.03 0.36±0.04 
B(a)P 7.5 Microsomes 0.63+.0.02 0.67±0.03 
Pre-incubation was for 2 hr. Values are means of five determinations per expe-
riment and asteriks indicate a significant decrease (P<0.01, by Wilcoxon's 
test) after I3C pretreatment. 
When the effects of pretreatment were studied using an S-9 mix as the metabo-
lizing system, a 45% decrease in mutagenicity was observed, whereas no signi-
ficant difference was observed when the microsomal fraction was used. These 
data point to an important role for cytosolic enzymes or cytosolic cofactors, 
which are present in the S-9 mix but not in the microsomal fraction. The some-
what higher mutagenic effect obtained for B(a)P with S-9 compared with the 
microsomal fraction may be due to the fact that NADPH was used with the micro-
somal fraction, whereas in the case of the S-9 mix a regenerative system was 
used. 
B(a)P metabolism 
Pretreatment of the hepatocytes with I3C resulted in induction of cytochrome 
P450 associated enzyme activities which catalyze different reactions. There-
fore the effects of pretreatment on microsomal B(a)P metabolism were studied 
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i n more d e t a i l . Table VIII shows the data on the formation of B(a)P 
metabol i tes in chick-embryo hepat ic microsomes which were p re t r ea t ed in ovo 
with 3-MC and I3C. 
Table VIII Formation of benzo(a)pyrene metabolites in chick-embryo hepa t i c 
microsomes treated in ovo with 3-methylcholanthrene and indole-3 
carbinol. 
Treatment 
Metabolite formation(*) 
Dihydrodiols 
D9.10 D4.5 D7.8 Quinones 90H 30H 
control 0.073 0.022 0.082 0.13 0.035 0.034 
3-MC 0.22 
induction factor 3.0 
I3C 0.13 
induction factor 1.8 
0.027 0.56 
1.2 6.8 
0.030 0.31 
1.4 3.8 
0 . 3 0 
2 . 3 
0 . 2 2 
1.7 
0 . 3 4 
9 . 7 
0 . 2 5 
7 . 1 
0 . 7 6 
2 2 . 4 
0 . 4 1 
1 2 . 1 
* Activity is expressed as nmol/min/nmolP450. Treatment with I3C is 3.0 mg/egg 
and with 3-MC is 0.5 mg/egg. D9.10- B(a)P-9,10-dihydrodiol; D4,5= B(a)P-4,5-
dihydrodiol; D7,8« B(a)P-7,8-dihydrodiol. 
For both compounds the overall metabolism of B(a)P is considerably increased. 
However when the profiles of metabolite formation of the two compounds were 
compared no major differences could be observed in induction ratios. The 
overall ratio of metabolite formation was 1.6 (3-MC/I3C).The ratios for the 
various metabolites, with the exception of the B(a)P-4,5-dihydrodiol ranged 
between 1.4-1.9. Especially formation of the proximate carcinogenic metabolite 
B(a)P-7,8 dihydrodiol did not differ between the two compounds. 
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DISCUSSION 
Pretreatment of primary chick-embryo hepatocytes in vitro with naturally oc-
curring indoles leads to a reduced induction of SCEs after exposure of the 
cells to B(a)P. The modulating effects of the investigated compounds differed 
qualitatively. Pretreatment with I3C leads to reduced genotoxic effects with 
NDMA whereas no reduction was found with I3A. No inhibitory effects were ob-
served with both indoles when 2AA was tested and when DBE was tested pretreat-
ment with I3C resulted in an increase in the number of SCEs. The latter obser-
vation may be explained by the observations of van Bladeren et al. (1980) 
that DBE is activated into a more potent mutagen mainly by glutathione conju-
gation and to a lesser extent by microsomal oxydation. Apparently the charac-
ter of the modulating effects is largely dependent on the choice of the model 
compounds and the metabolic routes leading to the formation of reactive inter-
mediates formed from them. 
Several lines of evidence, presented in this paper indicate that the inhi-
bitory effects of pretreatment with the indoles do not correlate with the 
induction pattern of cytochrome P450 associated enzymes. (1) Although I3C gave 
a much higher increase in EROD activity than I3A, the inhibitory effects on 
B(a)P mediated SCE induction are quantitatively similar. (2) Both indoles give 
a similar induction of ETCO activity. Nevertheless, their inhibitory effects 
on NDMA mediated SCE induction are completely different. Pretreatment with I3C 
gave a reduction in SCEs quantitatively similar to the effects elicited with 
B(a)P, whereas no reduction was found when the cells were pretreated with I3A 
(Table III and IV). It is apparent that also in the case of NDMA, the ETCO 
induction pattern of indole pretreatment is not directly correlated with the 
protective effects. (3) When the hepatocytes were pretreated with I3C for a 
period in which induction of EROD activity was approximately one third of the 
maximum, a considerable decrease in B(a)P-induced SCEs was still observed, 
indicating the involvement of other enzyme systems having different induction 
kinetics. (4) The results obtained with enzyme fractions prepared from I3C 
pretreated hepatocytes showed that the use of the S-9 fraction gave similar 
results to those obtained with intact cells, but when the microsomal fraction 
prepared from the same cells was used, the protective effect disappeared. This 
indicates that cytosolic enzymes play an essential role in the protective 
effects. (5) When the pattern of metabolite formation of B(a)P after in ovo 
treatment with I3C was compared with treatment with 3-MC, no major differences 
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could be observed. The formation of the proximate carcinogenic metabolite 
B(a)P-7,8 dlhydrodiol was increased with a factor 3.8 compared to the value 
obtained with non-treated hepatic microsomes. 
When different periods of exposure to B(a)P are compared, it seems that at the 
longer exposure time (24 h) the protective effects of pretreatment are smaller 
(Table III) than with the 4-h exposure period (Table V ) . Probably, after a 
longer exposure time, the biotransformation process of the genotoxic agent 
itself influences the balance of the enzyme systems, giving a decrease in the 
protective effect. Additional support for this hypothesis was given by the 
data obtained with the S-9 fraction which showed the same percentage decrease 
as was obtained with the 4-h exposure to B(a)P (Table VII). 
Figure II shows that I3A and I3C are both competitive inhibitors of EROD 
activity. This implies that they can also act as competitive inhibitor for 
B(a)P. In theory, pretreatment with the indoles may lead to the formation of 
an intracellular pool of these compounds. When pretreatment is followed by 
exposure to B(a)P the intracellular pool of indole can compete with the meta-
bolism of B(a)P resulting in a reduction in the formation of mutagenic com-
pounds. However the data found in the mutagenicity experiments do not support 
the hypothesis that this effect plays a dominant role in the protective 
effects observed. Firstly, when the cells were pretreated with I3C, followed 
by exposure to different doses of B(a)P, the percentage of decrease of the 
number of SCEs was positively correlated with the dose of B(a)P applied. 
Secondly, when microsomal fractions were prepared from cells pretreated with 
I3C no increase in mutagenicity was observed. Apparently the observed increase 
in metabolite formation after treatment with I3C is not reflected in larger 
mutagenic effects. 
The data presented here indicate that the protective effects of pretreatment 
with indoles do not correlate with the induction of cytochrome P450 associated 
enzymes but seem to be more the result of a changed balance in the enzyme 
systems involved in the biotransformation of these indoles. Support for this 
hypothesis is given by the finding that the ratio between UDPGT activity and 
cytochrome P450 content is much higher for 3-MC than for I3C where the in-
crease in UDPGT activity seems to be in balance with cytochrome P450 content. 
UDPGT activity requires the presence of cytosolic cofactors. Consequently it 
does not play a role in the effects obtained with microsomal fractions. The 
use of a microsomal fraction prepared from hepatocytes pretreated with I3C 
gave the same number of SCEs as the microsomes prepared from non-pretreated 
cells. The increased potential of pretreated microsomes to metabolize B(a)P is 
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not reflected in larger genotoxic effects. This points to an important role 
for the enzyme epoxide hydrolase. This hypothesis is also in agreement with 
the findings of other authors, who have reported induction of other enzymes, 
such as glutathione-S-transferase in rats (Sparnins et al., 1982) or epoxide 
hydrolase in rats (Henrich and Bjeldanes, 1983). 
The pretreatment of metabolizing cells with naturally occurring indoles not 
only modulates the carcinogenic potency of B(a)P in vivo but also has a pro-
tective effect on the SCE induction of this compound in vitro. It should be 
emphasized that the type of effect resulting from indole treatment depends 
largely on the chemical properties of the mutagenic mutagenic agents. 
The co-cultivation system consisting of primary chick-embryo hepatocytes and 
V79 Chinese hamster cells offers a promising in vitro model for studying the 
modulating effects of compounds on the genotoxic activity of indirectly acting 
xenobiotics. 
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B. MODULATING EFFECTS OF B-NAPHTOFLAVONE ON THE INDUCTION OF SCEs BY MODEL 
COMPOUNDS WITH EMPHASIS ON BENZO(A)PYRENE 
ABSTRACT 
The inducing capability of the synthetic flavonol B-naphtoflavone on cyto-
chrome PA50 content was studied in primary chick-embryo hepatocytes. In addi-
tion, the modulating effects of pretreatment with B-NF on the induction of 
SCEs by mutagens from different chemical classes were investigated. Finally, 
the effects of pretreatment on B(a)P metabolism were studied more detailed. 
Pretreatment of cultured primary chick-embryo hepatocytes with B-naphtoflavone 
resulted in a large increase in cytochrome P450 content (a 2.8-fold increase 
after 31 hr). Pretreatment with B-NF had no effect on the level of SCEs indu-
ced by N-nitrosodimethylamine (NDMA) and 2-aminoanthracene (2AA). Pretreatment 
with B-NF resulted in a decrease in B(a)P induced SCEs. This inhibitory poten-
tial was positively related to the B-NF dose; its magnitude did depend on the 
dose of B(a)P, at higher doses less inhibition was observed. 
When B-NF was applied simultaneously with B(a)P the percentage of decrease was 
about the same as for pretreatment. Pretreatment with B-NF followed by simul-
taneous application of B-NF and B(a)P did not result in larger effects. 
In addition, subcellular fractions were prepared from chick-embryos pretreated 
in ovo. The use of the S-9 fraction resulted in a large decrease (80%) in the 
induction of SCEs by B(a)P whereas the use of the microsomal fraction resulted 
in a 70% increase in SCE induction,when compared with non-pretreated micro-
somes. Pretreatment with B-NF in ovo gave rise to a large increase in aryl 
hydrocarbon hydroxylase (AHH) activity. With all metabolites studied increases 
in the amounts formed from B(a)P were observed. The formation of one of these 
metabolites, the proximate carcinogenic and mutagenic metabolite B(a)P-7,8-
dihydrodiol was seven-fold increased. 
The data strongly suggest that the inhibitory effects of pretreatment of 
cultured primary chick-embryo hepatocytes with B-NF cannot be ascribed to its 
inducing capabilities but instead seem to be due to the formation of an intra-
cellular pool of B-NF which acts as a competitive inhibitor for B(a)P 
metabolism. 
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INTRODUCTION 
Naturally occurring flavonoids are present in many edible plants and their 
estimated daily intake via the American diet amounts to 1 gram (Brown, 1980). 
Representatives of this class of compounds like quercetin, rutin, tangeretin 
and nobiletin have been shown to possess anticarcinogenic properties in expe-
rimental animals (Wattenberg et al., 1968; Wattenberg and Leong, 1970). The 
anticarcinogenic potential of these compounds has been ascribed to their 
potential to act as enzyme inducers (Wattenberg et al., 1968; Wattenberg and 
Leong, 1970; Cutroneo et al., 1972; Friedman et al, 1985). 
B-Naphtoflavone is a synthetic flavone (5,6-benzoflavone) which is a known 
potent inducer of cytochrome P448 (Althaus and Meyer, 1981; Nash, 1981; 
SSderkvist et al., 1982). In several papers it has been reported that 
B-naphtoflavone has anticarcinogenic properties (Wattenberg et al., 1968; 
Wattenberg and Leong, 1970; Slaga et al., 1977; Wattenberg, 1978). In mice 
B-NF inhibited dimethylbenzanthracene (DMBA) induced tumor formation and bin-
ding of DMBA metabolites to DNA was decreased (Bowden et al., 1974). Another 
study reported contradictory effects of B-NF mediated modulation of tumor 
formation in experimental animals. When a mouse strain, which was not very 
sensitive to the tumorigenic potential of DMBA, was pretreated with B-NF a 
good correlation was found between the increase in aryl hydrocarbon hydroxy-
lase (AHH) activity and an increase in tumor formation. When mice were used, 
which were highly sensitive for the tumorigenic potential of DMBA, the 
increase in AHH activity was correlated with a decrease in tumor formation and 
a decrease in the formation of DNA adducts. (Lesca, 1981). These findings 
suggest that the observed effects, caused by B-NF pretreatment, resulted from 
a changed balance between activating and detoxifying enzymes. 
Recently, Topp and van Bladeren (1986) showed that B-NF was capable of induc-
tion of cytochrome P450 in cultured primary chick-embryo hepatocytes. The 
reported anticarcinogenic properties of this compound in animal studies were 
suggested to be related to the enzyme inducing capability of this compound. 
Therefore it was decided to study the effects of pretreatment with B-NF on the 
mutagenicity of model compounds from different chemical classes, using a co-
cultivation system consisting of primary chick-embryo hepatocytes and V79 
Chinese hamster cells. Mutagenicity was determined as the number of sister 
chromatid exchanges in V79 cells. In addition the mode of action of pretreat-
ment with B-NF on benzo(a)pyrene metabolism was studied in more detail. 
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MATERIAL and METHODS 
Arvl Hydrocarbon Hydroxylase (AHR) Activity 
Composition of the incubation mixture and the procedure followed were as des-
cribed under: B(a)P metabolite formation (Chapter VIa;M&M). Total conversion 
of B(a)P was measured with [ H] B(a)P in microsomes. AHH activity was deter-
mined from regression lines which were calculated from time-course experi-
ments . For practical reasons, in the experiments where the modulating effects 
of B-NF were investigated a treatment time of 22 hr was applied. 
All other material and methods are identical to those used in the experiments 
with the indoles and are described in chapter Via. The concentrations of B-NF 
used are given in legends to figures and tables. 
RESULTS 
Enzyme induction 
Figure I Effect of B-naphtoflavone on the cytochrome P-450 content in 
primary chickembryo hepatocytes. 
p mot P-450 
mg protein 
80 100 
time (h) 
Treatment with B-NF (o) was with 6 /jg/ml. Data represent mean ± SEM of six 
experiments. Figure is modified from Topp and van Bladeren (1986). 
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Topp and van Bladeren (1986) studied the induction of cytochrome P450 in cul-
tured primary chick-embryo hepatocytes by B-NF; they found that 6 pg/ml gave 
maximal induction. A time-course experiment, taken from that study, is depic-
ted in figure I. 24 hr after the hepatocytes were plated, treatment with B-NF 
was started. Maximal induction was reached at 31 hr after start of the treat-
ment and amounted to a 2.8 fold increase in the cytochrome P450 content. 
Mutagenicity studies 
Pretreatment with B-NF resulted in a lower frequency of benzo(a)pyrene [B(a)P] 
induced SCEs (Table I). 
Table I Inhibitory effects of pretreatment of primary chick-embryo hepa-
tocytes with B-naphtoflavone (B-NF) on the mutagenicity of benzo-
(a)pyrene [B(a)P] after co-cultivation with V79 Chinese hamster 
cells. 
TREATMENT 
B-NF(/ig/ml) 
0 
6.0 
0 
2.0 
4.0 
6.0 
B(£ i)P(/ig/ml) 
0 
0 
7.5 
7.5 
7.5 
7.5 
SCEs/CHROMOSOME 
0.22±0.03 
0.20±0.02 
0.88±0.05 
0.80±0.04 
0.73±0.06 
0.64±0.05 
Decrease (%) 
-
-
-
9(*) 
20(*) 
33(*) 
Treatment time with B-naphtoflavone was 22 hr. Exposure time for B(a)P was 4 
hr. Data ±SEM are average values of one representative experiment carried out 
in four-fold. Asteriks indicate a significant decrease (P<0.05, by Wilcoxon's 
test). 
This reduction was related to the dose of B-NF applied and amounted to a 33% 
decrease at 6 /ig/ml. In table II the results of experiments with model com-
pounds from different chemical classes are summarized. 
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Table II Inhibitory effects of pretreatment of primary chick-embryo hepa-
tocytes with B-NF on the mutagenicity of model compounds from 
different chemical classes after co-cultivation with V79 Chinese 
hamster cells. 
Dose SCEs/chromosome Decrease 
Exposure (/ig/ml) Without B-NF With B-NF (%) 
Control 
B(a)P 
DMNA 
2AA 
2.5 
5.0 
7.5 
1000.0 
1500.0 
5.0 
10.0 
0.20±0.01 
0.4710.03 
0.59±0.04 
0.8410.05 
1.21±0.05 
1.68±0.05 
0.47±0.03 
0.62±0.04 
0.20±0.02 
0.35±0.04 
0.45±0.04 
0.7010.03 
1.2510.07 
1.6410.05 
0.5110.03 
0.6310.06 
-
44(*) 
36(*) 
22(*) 
. 
-
. 
-
B-NF- B-naphtoflavone; B(a)P-benzo(a)pyrene; NDMA- dimethylnitrosamine; 2AA-
2-aminoanthracene. Exposure to the model compounds was 4 hr. Pretreatment with 
B-NF was with 6 Mg/ml f° r 22 hr. Data 1 SEM are average values of one repre-
sentative experiment carried out in fourfold. Asteriks indicate a significant 
decrease (P<0.05, by Wilcoxon's test). 
Pretreatment with B-NF was with 6 /ig/ml in these experiments. When different 
doses of B(a)P were tested, the percentage of inhibition, caused by B-NF pre-
treatment, decreased with increasing B(a)P exposure. In contrast to the data 
obtained with B(a)P, no inhibitory effects of pretreatment were observed for 
NDMA and 2AA. In addition to pretreatment with B-NF the effects of simulta-
neous exposure to B(a)P and B-NF were studied also (Table III). 
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Table III Comparison of different treatment procedures on the inhibitory 
potential of B-naphtoflavone (B-NF) on benzo(a)pyrene [B(a)P] 
mediated mutagenicity in a co-cultivation system. 
B-NF treatment 
pretreatment simultaneous 
Exposure 
[B(a)P] 
0 
0 
0 
7.5 
7.5 
7.5 
7.5 
SCEs/chromosome 
0.20±0.02 
0.21±0.01 
0.23±0.02 
0.84±0.05 
0.70±0.03 
0.65+0.04 
0.67±0.08 
Decrease 
(%) 
-
-
-
-
23(*) 
30(*) 
28(*) 
Exposure to B(a)P was for 4 hr. Treatment with B-NF was with 6 /jg/ml. Pre-
treatment was for 22 hr, simultaneous treatment was for 4 hr. Data ± SEM are 
average value of one representative experiment carried out in four-fold. Aste-
riks indicate a significant decrease (P<0.05, by Wilcoxon's t e s t ) . 
Pretreatment of the primary chick-embryo hepatocytes gave the expected de-
crease in the number of SCEs/chromosome. Simultaneous application of B-NF and 
B(a)P gave a s l ight ly larger decrease than did pretreatment- However when the 
hepatocytes were pretreated with B-NF and this compound was also present 
during B(a)P exposure no additional effect of simultaneous treatment was 
observable. 
To find out which mechanisms are responsible for these effects of B-NF, enzyme 
fractions were prepared from in ovo induced chick-embryos. 
A comparative study of in vi tro and in ovo induction, which wil l be published 
separately, showed that no quali tat ive differences in B(a)P metabolism and 
metabol i te pa t te rns were observable following pretreatment with different 
types of inducers l ike 3-methylcholanthrene, and Aroclor 1254 ( van Bladeren 
et a l . , in preparation). 
F i rs t ly , experiments were done with different subcellular fractions summa-
rized in table IV. 
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Table IV Comparison of the genotoxic effects of benzo(a)pyrene [B(a)P] in 
a pre-incubation assay with V79 Chinese hamster cells using 
different hepatic enzyme fractions prepared from chick-embryos 
pretreated with B-naphtoflavone (B-NF). 
Treatment 
Dose Enzyme 
SCEs/chromosome 
Change 
(/ig/ml) fraction Without B-NF With B-NF (%) 
Control S-9 0.24±0.01 0.27±0.01 
B(a)P 7.5 S-9 1.16±0.02 0.47+.0.04 -78** 
Control 0 Microsomes 0.22+0.01 0.23±0.03 
B(a)P 7.5 Microsomes 0.72±0.04 1.46±0.02 +68** 
Pre-incubation was for 2 hr. Values are means + SEM of five determinations per 
experiment and asterisks indicate a significant change (P<0.01, by Wilcoxon's 
test) after B-NF pretreatment. 
In these experiments NADPH was used as cofactor for both enzyme fractions. 
When the S-9 fraction was used, pretreatment with B-NF resulted in a 78% 
reduction in B(a)P mediated mutagenicity. This effect is much larger than that 
observed after in vitro pretreatment. However when the microsomal fraction was 
used the opposite phenomenon was observed. Pretreatment with B-NF resulted in 
an increase in the induction of SCEs by B(a)P with 68%. 
B(a)P metabolism 
Secondly the metabolism of B(a)P was studied in more detail. Table V summa-
rizes the effects of pretreatment with B-NF on induction of aryl hydrocarbon 
hydroxylase (AHH) activity. 
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Table V Induction of aryl hydrocarbon hydroxylase (AHH) activity in chick 
embryo hepatic microsomes, treated in ovo with 3-methylcho-
lanthrene (3-MC) and B-naphtoflavone (B-NF). 
AHH ACTIVITY 
mg protein* nmol cytochrome P450** 
Treatment activity I.F. activity I.F. 
Control 0.040 0.412 
3-MC 0.821 20.5 2.55 61.9 
B-NF 0.860 21.5 3.32 80.6 
(*) Enzyme activity is expressed as nmol 3-0H-B(a)P/min/mg protein. (**) 
Enzyme activity is expressed as nmol 3-OH-B(a)P/min/nmol cytochrome P450. 
I.F.-induction factor. 15-Day old chick-embryos were injected twice with a 24 
hr time interval with 3-MC (0.5 mg/egg) and B-NF (0.75 mg/egg). 
A comparison was made between the effects of B-NF and those of 3-MC. The data 
show that both compounds give a considerable increase in AHH activity both 
when expressed per mg protein and when expressed per nmol cytochrome P450 
with B-NF giving the largest increase. In the same enzyme fractions the 
pattern of metabolite formation from B(a)P was studied (Table VI). Treatment 
with both inducers leads to considerable increases in the amount of all meta-
bolites formed. When the patterns of metabolite formation were compared no 
major differences were observable between 3-MC treatment and B-NF treatment. 
Both compounds gave a seven-fold increase in the amount of the proximate 
carcinogenic and mutagenic metabolite B(a)P-7,8-dihydrodiol (D7,8). The only 
clear difference between the two inducers is that the formation of the 
B(a)P-4,5 dihydrodiol is much more increased after B-NF treatment than with 
3-MC. 
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Table VI Formation of benzo(a)pyrene metabolites in chick-embryo hepatic 
microsomes pretreated in ovo with 3-methylcholanthrene (3-MC) and 
B-naphtoflavone (B-NF). 
METABOLITE FORMATION* 
Treatment 
Control 
3-MC 
I.F. 
B-NF 
I.F. 
Dihydrodiols 
D9.10 
0.073 
0.22 
3.0 
0.30 
4.1 
D4,5 
0.022 
0.027 
1.2 
0.093 
4.2 
D7,8 
0.082 
0.56 
6.8 
0.55 
6.7 
Quinones 
0.13 
0.30 
2.3 
0.51 
3.9 
90H 
0.035 
0.34 
9.7 
0.31 
8.9 
30H 
0.034 
0.76 
22.4 
1.03 
30.3 
* Activity is expressed as nmol/min/nmol cytochrome P-450. D9.10- B(a)P9,10-
dihydrodiol; D4,5- B(a)P-4,5-dihydrodiol; D7,8- B(a)P-7,8-dihydrodiol. 15-Day 
old chick-embryos were injected twice with a 24 hr time interval with 3-MC 
(0.5 mg/egg) and B-NF (0.75 mg/egg). I.F.- induction factor. 
DISCUSSION 
When the effects of pretreatment with B-NF on SCE induction by various model 
compounds were compared no decrease was observed for NDMA and 2-AA. Obviously 
the modulating effects of B-NF are restricted to premutagens which are acti-
vated via specific biotransformation routes. 
Pretreatment of primary chick-embryo hepatocytes with B-NF leads to reduced 
genotoxic effects after exposure of the cells to B(a)P. When the effects of 
pretreatment were compared with simultaneous exposure the reduction in geno-
toxicity was approximately the same for both types of treatment. The obser-
vation that pretreatment followed by simultaneous application of B-NF did not 
result in a larger decrease than either one of them, combined with the 
observed decrease in inhibition with increasing B(a)P exposure, raised the 
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question whether it is justified to ascribe the inhibitory potential of B-NF 
to its inducing capabilities. Several lines of evidence argue against this 
explanation. Pretreatment with B-NF leads to a large increase in AHH activity, 
the enzyme responsible for the activation of B(a)P into its mutagenic metabo-
lites. This is confirmed in experiments where the metabolite pattern was stu-
died. For example, the amount of the proximate carcinogenic and mutagenic 
metabolite D7,8 was increased seven-fold. Also when mutagenicity experiments 
were performed with the microsomal fraction pretreatment with B-NF gave a 
large increase in the number of SCEs compared with non-pretreated microsomes. 
A possible explanation for the way B-NF exhibits its inhibitory potential 
would be the presence of residual B-NF either in the intact cells or in the 
S-9 fraction after pretreatment. As was seen in the experiments on B(a)P meta-
bolism, B-NF specifically induces AHH activity to a large extent. Obviously, 
AHH is the enzyme responsible for the metabolism of B(a)P into its mutagenic 
intermediates. Consequently, B-NF can be considered a competitive inhibitor of 
B(a)P metabolism. The presence of B-NF in the intact cells would then lead to 
a reduced conversion of B(a)P compared with a situation where no residual B-NF 
is available. This explanation would also clarify why the dose-response rela-
tionship for B(a)P is inversely related with the percentage of inhibition. 
Increasing the dose-level of B(a)P would cause a shift in the competition 
between the metabolism of B(a)P and B-NF favoring B(a)P metabolism. In ad-
dition it would clarify why, in the experiments with subcellular fractions, 
the use of an S-9 fraction gives a large decrease in mutagenic effects whereas 
the use of a microsomal fraction gives a considerable increase in the number 
of SCEs compared with non-pretreated microsomes. When S-9 fractions are used 
residual B-NF would still be present whereas the microsomal fraction would not 
contain residual B-NF. Finally it would explain why the effects of pretreat-
ment and simultaneous exposure are comparable and that combined treatment does 
not give a larger decrease in SCE induction. 
In conclusion, the data presented in this study strongly suggest that the 
inhibitory effects of pretreatment of cultured primary chick-embryo hepato-
cytes with B-NF cannot be ascribed to its inducing capabilities but instead 
seem to result from the formation of an intracellular pool of B-NF which acts 
as a competitive inhibitor for B(a)P metabolism. 
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CHAPTER VII 
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SUMMARY AND CONCLUDING REMARKS 
Epidemiological data show that in western societies 1 out of 3 persons gets 
cancer and 1 out of 4 persons dies of cancer. This makes cancer, next to heart 
and vascular diseases, a major cause of death. There are three major factors 
contributing to the cancer death rate in humans: 
1. ionizing radiation 
2. certain viruses 
3. chemicals 
Intensive research efforts for many decades have led to the development of a 
generalized concept which implies that the process of tumor formation proceeds 
stepwise. This stepwise development includes both genetic and epigenetic fac-
tors. 
In this thesis studies are described which were aimed at the development of an 
in vitro system enabling the study of the effects of compounds on various 
important aspects of the cancer process. In the first chapter a description is 
given of the cancer process as it emerges from epidemiological data and data 
from studies with experimental animals. The process can be divided in three 
more or less distinct phases: the initiation phase, the promotion phase and 
the progression phase. Within the concept presented, the role of intercellular 
communication was emphasized and inhibition of intercellular communication has 
been described as an essential step in tumor promotion. In addition the role 
of drug metabolism in the formation of reactive intermediates is described 
briefly and the advantages of the principle of using intact cells, compared 
with subcellular fractions is discussed. Finally the objectives of the inves-
tigations are presented. 
In chapter II the principles of the test methods used in the investigations 
are described, including methods determining interactions of chemicals with 
DNA of cells as well as methods designed to study effects of compounds on 
intercellular communication. 
Chapter III deals with the relation between the sensitivity of the co-culti-
vation system, the genetic endpoint and the type of xenobiotic It was shown 
that the use of primary chick-embryo hepatocytes as an activation system sho-
wed the best performance compared with subcellular fractions from chick-embryo 
liver and rat liver pretreated with Aroclor 1254. Induction of SCEs in V79 
Chinese hamster cells is no good endpoint to determine the potential of ciga-
rette-smoke condensate (CSC) to interact with DNA. The small but consistently 
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observed increase in the number of SCEs after exposure could not be ascribed 
to a reaction of CSC with DNA of V79 cells. In contrast, the complex mixture 
was clearly positive in the test on forward mutation at the HGPRT locus. 
When a co-cultivation system is used to study the interactions of reactive 
intermediates with DNA of cells, the transport of reactive intermediates is of 
vital importance for an adequate measurement of these interactions. Any factor 
disturbing the transport from drug metabolizing cells to target cells influen-
ces the outcomtive intermediates. From the data obtained with time-course 
studies and those obtained with different mutagens it was concluded that this 
type of transport is not restricted to specific types of ultimate mutagens but 
is a phenomenon of a more general nature. If this transport occurs in vivo 
this might have consequences as to which cells in a given tissue are at risk 
to become neoplastic upon exposure to mutagens. For example, drug metabolizing 
cells like the primary chick-embryo hepatocytes are protected more efficiently 
against toxic intermediates than non metabolizing cells like the V79 cells. 
Definitive evidence that functional heterologous gap junctions are formed 
between the two cell types used in the co-cultivation system is given in 
chapter V. 
The purpose of the studies presented in this chapter was twofold. The first 
aim was to investigate whether functional gap junctions are really formed 
between the two cell types and the second aim was to study the possibility to 
develop a test system measuring inhibition of metabolic cooperation using the 
co-cultivation system. The presence of gap junctions was visualized with 
transmission electron microscopy. The formation of heterologous gap junctions 
was difficult to determine. In contrast to homologous gap junctions, the hete-
rologous gap junctions were very small and could be recognized merely by the 
closeness of the opposing membranes. Studies on the transfer of labeled nu-
cleotides showed unequivocally that the heterologous gap junctions were func-
tional. Addition of the phorbolester TPA inhibited this transfer, which was 
accompanied by the disappearance of all gap junctions. Upon longer treatment 
times transfer was partly restored and also morphologically the gap junctions 
reappeared. It was shown that this adaptation is associated with the mitotic 
index of the cells. 
A model system was developed, enabling the study of the role of drug metabo-
lism in the formation of compounds with the potential to inhibit intercellular 
communication. This model is based on the use of a mutant (HGPRT-) V79 cell 
line which lacks the capacity to phosphorylate hypoxanthine. These mutant V79 
cells are co-cultured with primary chick-embryo hepatocytes in the presence of 
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[3H] hypoxanthine. The HGPRT- V79 cells are not capable of phosphorylating 
this hypoxanthine and cannot incorporate the label in the genetic material. 
Only when the hypoxanthine is phosphorylated by the primary chick-embryo 
hepatocytes and is transported through gap junctions to neighbouring HGPRT-
V79 cells, incorporation will occur. Incorporation of label is visualized with 
autoradiographic methods and the accurate number of grains can be determined 
by counting them under the microscope. When TPA and CSC were tested with this 
method, both were able to inhibit this transfer. When the effect of CSC on 
disappearance of gap junctions was investigated at cytotoxic concentrations, 
no decrease in the number of gap junctions was found. In the same system the 
complex mixture inhibits metabolic cooperation. Therefore the conclusion was 
drawn that inhibition of intercellular communication can be accomplished along 
different metabolic pathways. 
When dimethylbenzanthracene, an indirect acting carcinogen was tested at non-
cytotoxlc concentrations, it inhibited the transfer of labeled nucleotides 
completely. No effect was found when the compound was tested in the assay 
using the transfer of a poisonous base analogue between two types of V79 
cells. Since V79 cells lack the capacity for drug metabolism it was assumed 
that not the parent compound but one or more of its metabolites is responsible 
for the observed effects. This compound is the first example of an indirect 
acting inhibitor of intercellular communication which emphasizes the impor-
tance of the use of adequate drug metabolizing systems. 
Chapter VI deals with studies on cancer modulating effects of various com-
pounds. These studies comprize investigations towards enzyme inducing capa-
bilities and the effects of pretreatment on SCE induction by mutagens from 
different chemical classes. In addition the effects of pretreatment on benzo-
(a)pyrene "'B(a)Pfc metabolism were studied in detail. 
In the first part the effects of two naturally occurring indoles, indole-3-
carbinol (I3C) and indole-3-acetonitril (I3A) were examined. Both compounds 
induced the cytochrome P450 associated enzymes EROD and ETCO in cultured pri-
mary chick-embryo hepatocytes. Induction was observed also for UDPglucuronyl-
transferase whereas no induction of glutathione-S-transferase was found. I3C 
was a better inducer than I3A; the increases in enzyme activity were larger 
and obtained at a lower concentration than that of I3A. 
The effects of pretreatment with the indoles on SCE induction by mutagens from 
different chemical classes were studied. Pretreatment with I3C resulted in a 
decrease in SCE induction for B(a)P and dimethylnitrosamine (NDMA). No diffe-
rence was found for 2-aminoanthracene (2-AA) and the direct acting mutagen 
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ethylmethanesulfonate (EMS). On the other hand an increase in SCE induction 
was found with dibromoethane (DBE). 
Pretreatment with I3A resulted in a decrease in SCE induction by B(a)P whereas 
no decrease was observed for NDMA, 2-AA and EMS. Apparently there are also 
qualitative differences between the modulating effects of I3C and I3A. Another 
conclusion is that the choice of the mutagen is crucial. The question whether 
pretreatment of metabolizing cells leads to decreased or enhanced effects on 
induction of SCEs, largely depends on the metabolic pathways involved in the 
biotransformation of the mutagens selected. As was shown, pretreatment with 
I3C leads to a reduced SCE induction by B(a)P whereas an increase was observed 
for DBE. 
The modulating effects of pretreatment with I3C on B(a)P-induced SCEs were 
studied in detail. The observation that both I3C and I3A are competitive inhi-
bitors for B(a)P metabolism could imply that the observed inhibitory effects 
on SCE induction are, at least partly, due to the presence of residual I3C or 
I3A inside the cells at the time of exposure to B(a)P. Although this cannot be 
ruled out completely, several lines of evidence argue against this possibi-
lity. First, the observed decrease in B(a)P induced SCEs is proportional to 
the dose applied. If competitive inhibition would play a significant role, 
increasing doses of B(a)P would decrease the protective effects of pretreat-
ment. Secondly, when microsomes prepared from pretreated chick-embryo hepato-
cytes were used, the increase in the formation of mutagenic intermediates from 
B(a)P is not reflected in an increase in SCE induction. This suggests that 
other enzyme systems play an essential role in the observed effects. Thirdly, 
the modulating effects of I3C are not restricted to a specific type of mutagen 
but comprizes mutagens from different chemical classes which are activated via 
different metabolic pathways. Especially in the case of dibromoethane pre-
treatment with I3C leads to an increase in SCE induction. 
Therefore it seems probable that competitive inhibition does not play a signi-
ficant role in the observed effects. Instead the modulating effects of pre-
treatment results from a changed balance between the enzyme systems involved 
in the biotransformation of the mutagens aplied and, in the case of B(a)P, 
point to an essential role of conjugating enzymes. 
In the second part of this study the modulating effects of B-naphtoflavone 
(B-NF), a synthetic flavonol with reported antil carcinogenic properties, were 
examined. B-NF treatment of cultured primary chick-embryo hepatocytes led to a 
large increase in cytochrome P450 content. No effect of pretreatment with B-NF 
on SCE induction by 2-AA and NDMA were observed. In contrast, a decrease in 
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the number of SCEs, induced by B(a)P was found. Detailed studies with sub-
cellular fractions, prepared from chick-embryo liver pretreated in ovo, showed 
that when an S9 fraction was used a large decrease in the number of SCEs was 
found whereas when a microsomal fraction was used, a large increase was found. 
Combined with the observed large increase in aryl hydrocarbon hydroxylase 
activity and the increase in formation of the proximate carcinogenic metabo-
lite B(a)P-7,8 dihydrodiol, this has led to the conclusion that enzyme induc-
tion by B-NF is not associated with a protective effect. Instead it was postu-
lated that the observed decrease in SCE induction by B(a)P in intact cells, 
stems from the formation of an intracellular pool of B-NF which acts as a 
competitive inhibitor for B(a)P metabolism. 
In conclusion it can be stated that the studies presented in this thesis 
illustrates that the combined use of different cell types with specific cha-
racteristics enables the study of various important aspects of the cancer 
process in vitro The results show that the co-cultivation system, consisting 
of primary chick-embryo hepatocytes and V7 9 Chinese hamster cells is a promi-
sing tool in cancer research. 
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SAMENVATTING EN DISCUSSIE 
Epidemiologische gegevens laten zien dat in westerse maatschappijen 1 van elke 
3 personen kanker krijgt en dat 1 van elke 4 personen aan kanker overlijdt. 
Kanker is dus naast hart- en vaatziekten een belangrijke doodsoorzaak. Er zijn 
drie belangrijke factoren bekend die bijdragen aan kanker als doodsoorzaak bij 
mensen: 
1. ioniserende stral ing 
2. bepaalde virussen 
3. chemische stoffen 
Intensief onderzoek gedurende tientallen jaren heeft geleid tot het formuleren 
van een algemeen aanvaarde hypothese die ervan uitgaat dat het proces van 
tumorvorming een meerstaps proces is. Deze stapsgewijze ontwikkeling wordt 
veroorzaakt door genetische en epigenetische factoren. 
In dit proefschrift worden experimenten beschreven die erop gericht waren een 
in vitro model te ontwikkelen dat het mogelijk maakt diverse belangrijke as-
pecten van het kanker proces nauwkeurig te bestuderen. 
In het eerste hoofdstuk wordt een beschrijving gegeven van het proces van 
tumor vorming zoals het naar voren komt uit epidemiologische gegevens en gege-
vens afkomstig uit studies met proefdieren. Tijdens het proces kunnen drie min 
of meer aparte fasen onderscheiden worden: de initiatie fase, de promotie fase 
en de progressie fase. In het beschreven model is de rol van intercellulaire 
communicatie benadrukt en remming van intercellulaire communicatie wordt be-
schouwd als een essentiële stap in de tumor promotie. Bovendien wordt aandacht 
besteed aan de rol van biotransformatie bij de vorming van reactieve interme-
diairen en de voordelen van het gebruik van intacte cellen versus subcellu-
laire fracties worden bediscussieerd. Tenslotte worden de doelstellingen van 
het onderzoek beschreven. 
In hoofdstuk II worden de principes van de gebruikte testsystemen behandeld. 
Deze omvatten zowel de methoden die zijn gebruikt om interacties van stoffen 
met het DNA van cellen vast te stellen als ook methoden die zijn ontwikkeld om 
effecten van stoffen op intercellulaire communicatie te meten. 
Hoofdstuk III gaat over het verband tussen de gevoeligheid van het gebruikte 
co-cultivatie systeem, de verschillende genetische eindpunten en de effecten 
van diverse chemische stoffen. Uit de resultaten bleek dat het gebruik van 
primaire, embryonale kippe-hepatocyten als activerend systeem de beste resul-
taten gaf vergeleken met subcellulaire fracties afkomstig van embryonale kippe 
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lever en ratte lever, voorbehandeld met Aroclor 1254. Inductie van SCEs (homo-
loge uitwisselingen tussen zusterchromatiden) in V79 Chinese hamster cellen is 
geen geschikt eindpunt om het vermogen van cigarette-rook condensaat (SRC) om 
met DNA te reageren te onderzoeken. De kleine maar voortdurend waargenomen 
verhoging van het aantal SCEs na blootstelling kon niet worden toegeschreven 
aan een reactie van SRC met het DNA van V79 cellen. In tegenstelling hiermee 
vertoonde het complexe mengsel een duidelijk positief effect in de test op 
voorwaartse mutaties op het HGPRT locus. 
Wanneer een co-cultivatie systeem wordt gebruikt om interacties van reactieve 
intermedialren met het DNA van cellen te onderzoeken is een adequaat transport 
van de reactieve intermediairen van vitaal belang voor het meten van dit type 
interacties. Elke factor die het transport van de cellen met biotransformatie 
capaciteit naar de doelcellen verstoort of beïnvloedt heeft een beslissende 
invloed op de uitkomsten van de experimenten. In hoofdstuk IV is het transport 
van reactieve intermediairen van de primaire, embryonale kippe-hepatocyten 
naar de V79 Chinese hamster cellen bestudeerd. In principe kan dit transport 
langs twee verschillende routes plaatsvinden, namelijk dwars door de cellu-
laire membranen en door de intercellulaire ruimte en via cel-cel kontakt waar-
bij gap junctions als een sluis functioneren. Als eerste werd aangetoond dat 
voor een adequaat transport van reactieve intermediairen de beide celtypen in 
ieder geval heel dicht tegen elkaar aan moeten liggen. Wanneer de cellen wer-
den behandeld met SRC of de phorbolester TPA, voordat blootstelling aan de 
mutagene stoffen plaatsvond, werden de mutagene effecten met ongeveer 50% 
gereduceerd. Hierbij werd geen verschil gevonden voor de verschillende eind-
punten. De phorbolester TPA is een bekende remmer van intercellulaire communi-
catie en behandeling van cellen met deze verbinding maakt elk transport door 
gap junctions onmogelijk. Deze waarnemingen suggereerden dat in dit co-culti-
vatie systeem heterologe gap junctions worden gevormd tussen de primaire, 
embryonale kippe-hepatocyten en de V79 Chinese hamster cellen en dat er trans-
port van reactieve intermediairen door deze gap junctions plaats kan vinden. 
Daarnaast suggereerden deze gegevens dat SRC mogelijk ook een remmer van in-
tercellulaire communicatie is. Toen SRC werd getest in een methode die gebruik 
maakt van de overdracht van giftige base-analogen tussen twee typen V79 cellen 
werd inderdaad gevonden dat het complexe mengsel metabole coöperatie tussen 
deze V79 cellen remde. De hypothese dat transport van reactieve intermediairen 
ook door heterologe gap junctions plaatsvond werd ook bevestigd met behulp van 
een mutante V79 cellijn die metabole coöperatie deficient is (MC~-27). Toen 
deze cellijn werd gebruikt waren de gegevens die ermee werden verkregen volle-
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dig vergelijkbaar met de gegevens die waren verkregen in aanwezigheid van TPA. 
De resultaten laten dan ook duidelijk zien dat in het gebruikte co-cultivatie 
systeem bij het transport van reactieve intermediairen routes van intercellu-
laire communicatie een belangrijke rol spelen. Uit experimenten met verschil-
lende mutagenen en studies naar effecten van kweektijden kan worden afgeleid 
dat dit type van transport niet beperkt is tot specifieke vormen van reactieve 
intermediairen maar een verschijnsel van algemene aard is. Indien deze vorm 
van transport ook in vivo een rol van betekenis speelt kan dat gevolgen hebben 
voor de vraag welke cellen het grootste risico lopen om geinitieerd te raken 
na blootstelling aan een mutagene stof. Bijvoorbeeld, cellen met biotransfor-
matie capaciteit zoals de primaire, embryonale kippe-hepatocyten zijn beter 
uitgerust om zichzelf te beschermen tegen toxische intermediairen dan cellen, 
zoals de V79 cellen, die geen biotransformatie capaciteit hebben. Het defini-
tieve bewijs dat functionele heterologe gap junctions worden gevormd tussen de 
beide cel typen zoals ze in het co-cultivatie systeem worden gebruikt wordt 
gepresenteerd in hoofdstuk V. 
De studies die in dit hoofdstuk worden gepresenteerd hadden een tweetal doel-
stellingen. Allereerst is nagegaan of er daadwerkelijk functionele gap junc-
tions kunnen worden gevormd tussen de beide cel typen en de tweede doelstel-
ling was om na te gaan of het mogelijk was, gebruik makend van het co-culti-
vatie systeem, een model te ontwikkelen waarmee remming van intercellulaire 
communicatie kan worden bepaald. 
De aanwezigheid van gap junctions werd zichtbaar gemaakt met transmissie 
electronenmicroscopie. De vorming van heterologe gap junctions was moeilijk 
vast te stellen. In tegenstelling tot homologe gap junctions bleken heterologe 
gap junctions zeer klein te zijn en hun aanwezigheid kon eigenlijk alleen maar 
worden afgeleid uit het tegen elkaar aan liggen van de beide tegenover elkaar 
liggende celmembranen. Experimenten waarbij gebruik werd gemaakt van de over-
dracht van radioactief gelabelde nucleotiden toonden echter ondubbelzinnig aan 
dat de heterologe gap junctions functioneel waren. Na toediening van de phor-
bolester TPA trad er volledige remming van deze overdracht op. Wanneer gekeken 
werd naar de morfologische aanwezigheid van gap junctions bleek dat de remming 
gepaard ging met het verdwijnen van alle gap junctions. Wanneer langere bloot-
stellings tijden werden toegepast bleek het transport via gap junctions ge-
deeltelijk te zijn hersteld en ook morfologisch bleken de gap junctions weer 
te verschijnen. Het kon worden aangetoond dat dit adaptatie verschijnsel sa-
menhangt met de delingssnelheid van de cellen. 
Een model systeem kon worden ontwikkeld dat het mogelijk maakt om de rol van 
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biotransformatie, bij de vorming van verbindingen die intercellulaire communi-
catie kunnen remmen, te bestuderen. Dit model is gabaseerd op het gebruik van 
een mutante (HGPRT deficiënte) V79 cellijn die het vermogen mist om hypoxan-
thine te phosphoryleren. Deze mutante V79 cellen worden samen gekweekt met de 
primaire, embryonale kippe-hepatocyten in de aanwezigheid van [^ H] hypoxan-
thine. De HGPRT deficiënte V79 cellen kunnen dit hypoxanthine niet phosphory-
leren en vervolgens incorporeren in het genetisch materiaal. Pas wanneer het 
hypoxanthine is gephosphoryleerd door de primaire, embryonale kippe-hepato-
cyten en vervolgens door de heterologe gap junctions naar aangrenzende HGPRT 
déficiente V79 cellen wordt getransporteerd zal inbouw in het genetische ma-
teriaal plaatsvinden. Deze inbouw wordt dan zichtbaar gemaakt met behulp van 
autoradiografie en het precieze aantal korrels kan worden bepaald door ze 
onder een licht microscoop te tellen. Toen de effecten van TPA en SRC werden 
onderzocht met deze methode bleken beide de overdracht van radioactiviteit te 
remmen. Toen de effecten van SRC op het verdwijnen van gap junctions werd 
onderzocht bij cytotoxische concentraties, werd geen afname van het aantal gap 
junctions waargenomen terwijl het complexe mengsel in hetzelfde systeem wel de 
intercellulaire communicatie remt. De conclusie lijkt dan ook voor de hand te 
liggen dat remming van intercellulaire communicatie via verschillende mecha-
nismen veroorzaakt kan worden. 
Toen dimethylbenzanthraceen, een indirect werkend carcinogeen werd onderzocht 
bij niet-cytotoxische concentraties, bleek ook deze verbinding in staat de 
overdracht van gelabelde nucleotiden volledig te remmen. Toen de verbinding 
werd onderzocht in het testsysteem waarbij gebruik wordt gemaakt van de over-
dracht van giftige base analogen tussen twee typen V79 cellen werd geen rem-
ming van metabole coöperatie waargenomen. Aangezien V79 cellen geen biotrans-
formatie capaciteit hebben ligt het voor de hand te veronderstellen dat niet 
de oorspronkelijke stof maar een of meer van zijn metabolieten verantwoorde-
lijk is voor de waargenomen effecten. Deze verbinding is waarschijnlijk het 
eerste voorbeeld van een indirect werkende remmer van intercellulaire communi-
catie hetgeen het belang onderstreept van het gebruik van adequate biotrans-
formatie systemen. 
Hoofdstuk VI handelt over onderzoek dat is verricht naar de modulerende effec-
ten van diverse verbindingen. Deze studies omvatten onderzoek naar het vermo-
gen van deze verbindingen om enzyminductie te veroorzaken als ook onderzoek 
naar de effecten van voorbehandeling met deze verbindingen op het vermogen van 
mutagenen van verschillende chemische klassen om SCEs te induceren. Bovendien 
werden de effecten van voorbehandeling op het metabolisme van benzo(a)pyreen 
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[B(a)P] in detail bestudeerd. 
In het eerste gedeelte werden de effecten van de van nature voorkomende indo-
len, indol-3-carbinol (I3C) en indol-3-acetonitril (I3A), onderzocht. Beide 
verbindingen bleken de cytochroom P450 geassocieerde enzymen EROD en ETCO in 
gekweekte primaire, embryonale kippe-hepatocyten te verhogen. Ook het enzym 
UDPglucuronyltransferase werd geïnduceerd terwijl geen effect werd waargeno-
men voor glutathion-S-transferase. I3C gaf grotere effecten dan I3A: de waar-
genomen verhogingen in enzymactiviteit waren groter en werden verkregen bij 
lagere concentraties. De effecten van voorbehandeling met beide indolen op het 
vermogen van diverse mutagenen om SCEs te induceren werd ook onderzocht. Voor-
behandeling met I3C resulteerde in een afname van SCE inductie door B(a)P en 
dimethylnitrosamine (NDMA). Geen verschil werd waargenomen voor 2-aminoanthra-
ceen (2-AA) en het direct werkende ethylmethaansulfonaat (EMS). Aan de andere 
kant werd een toename gevonden in het aantal SCEs wanneer blootstelling 
plaatsvond met dibromo-ethaan (DBE). 
Voorbehandeling met I3A resulteerde in een afname van SCE inductie door B(a)P 
terwijl geen afname werd gevonden voor NDMA, 2-AA en EMS. Blijkbaar zijn er 
ook kwalitatieve verschillen tussen de modulerende effecten van I3C en I3A. 
Een andere conclusie die getrokken kan worden is dat de keuze van het type 
mutagene verbinding van cruciaal belang is. De vraag of voorbehandeling van 
metaboliserende cellen leidt tot verminderde of verhoogde effecten hangt gro-
tendeels af van de omzettingsroutes die betrokken zijn bij de biotansformatie 
van de betreffende verbindingen. Zoals is aangetoond leidt voorbehandeling met 
I3C bij B(a)P tot een verminderd effect terwijl voor DBE een verhoging wordt 
waargenomen. De modulerende effecten van voorbehandeling met I3C op de induc-
tie van SCEs door B(a)P is in detail bestudeerd. De waarneming dat zowel I3C 
als I3A competitieve remmers zijn van het B(a)P metabolisme zou kunnen inhou-
den dat de waargenomen remmende effecten op SCE inductie, tenminste gedeelte-
lijk, verklaard zouden kunnen worden door de aanwezigheid van I3A en I3C in de 
primaire, embryonale kippe-hepatocyten ten tijde van de blootstelling aan 
B(a)P. Ofschoon deze mogelijkheid niet geheel kan worden uitgesloten zijn er 
diverse argumenten die tegen deze hypothese pleiten. Allereerst is de waarge-
nomen afname in inductie van SCEs door B(a)P proportioneel met de toegepaste 
doses. Als competitieve remming een significante rol zou spelen zou een toe-
name van de dosis B(a)P een afname van het beschermende effect van voorbehan-
deling te zien geven. Ten tweede, toen microsomen, afkomstig van voorbehan-
delde primaire, embryonale kippe-hepatocyten, werden gebruikt leidde de waar-
genomen toename in de vorming van mutagene intermediairen niet tot een toename 
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i n het aan ta l SCEs. Dit suggereer t dat andere enzymen een e s s e n t i ë l e r o l spe-
len b i j de waargenomen beschermende e f fec ten . Ten derde z i jn de waargenomen 
modulerende e f fec ten van I3C n i e t beperkt to t een spec iaa l type mutageen maar 
wordt de werking van mutagenen afkomstig u i t d iverse chemische k lassen be ïn-
v loed t . Speciaal i n het geval van DBE l e i d t voorbehandeling to t een toename 
van het a a n t a l SCEs. Daarom l i j k t het waarsch i jn l i jk dat competi t ieve remming 
n i e t een be langr i jke r o l s p e e l t b i j de waargenomen e f fec ten . In p l a a t s h ie rvan 
l i j ken de modulerende effecten van voorbehandeling toegeschreven te kunnen 
worden aan een verschuiving in de balans tussen de ve r sch i l l ende enzymen d ie 
betrokken z i j n b i j de b io t ransformat ie van de betreffende mutagenen en, in het 
geval van B(a)P, wijzen op een e s s e n t i ë l e r o l van conjugerende enzijmen. 
In het tweede gedeel te van deze s tud ie z i jn de modulerende e f f e c t e n van 
B-naphtoflavon (B-NF) bes tudeerd . B-NF i s een syn the t i sch f lavonol waarvan 
an t icarc inogene eigenschappen z i j n gerapporteerd in de l i t e r a t u u r . Behandeling 
van gekweekte p r imai re , embryonale kippe-hepatocyten le idde to t een gro te toe -
name van het cytochroom P450 geha l t e van deze c e l l e n . Voorbehandeling met B-NF 
had geen ef fec t op de induc t i e van SCEs door 2-AA en NDMA. In t e g e n s t e l l i n g 
hiermee werd wel een r educ t i e van het a a n t a l SCEs, veroorzaakt door B(a)P, 
gevonden. Gede ta i l l ee rde s tud ies met s u b c e l l u l a i r e f r a c t i e s , afkomstig van in 
ovo voorbehandelde embryonale kippe l e v e r , toonden aan dat wanneer een S-9 
f r a c t i e werd gebruikt een gro te afname in he t aan ta l geïnduceerde SCEs werd 
gevonden t e r w i j l b i j het gebruik van een microsomale f r a c t i e een grote toename 
werd gevonden. Gecombineerd met de waargenomen gro te toename in AHH a c t i v i t e i t 
en de gevonden toename in de vorming van de 'proximate ' carcinogene en muta-
gene metabol ie t B(a)P-7 ,8-dihydrodiol le idde d i t t o t de conclus ie dat door 
B-NF veroorzaakte toename in enzym a c t i v i t e i t n i e t i s geassocieerd met de 
beschermende e f fec ten . In p l a a t s h ie rvan werd geconcludeerd dat de waargenomen 
afname in SCE induc t i e door B(a)P afkomstig i s van de vorming van een i n t r a -
c e l l u l a i r e pool van B-NF die a l s competi t ieve remmer optreedt van het B(a)P 
metabolisme. 
Samenvattend kan ge s t e ld worden dat de s tud ies d ie in d i t p roe f sch r i f t worden 
gepresenteerd l a t en zien dat het gecombineerd gebruik van ce l l en met s p e c i -
f ieke eigenschappen het mogelijk maakt om diverse be langr i jke aspecten van het 
proces van tumor vorming in v i t r o t e bes tuderen. De r e s u l t a t e n l a t e n z i en dat 
he t c o - c u l t i v a t i e systeem, bestaande u i t p r ima i re , embryonale k ippe-hepa to-
cyten en V79 Chinese hamster c e l l e n een veelbelovend onderzoeksmodel i s i n he t 
kanker-onderzoek. 
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